|Ed Addison||Cloud Pharmaceuticals||AI in Pharma|
Ed Addison co-founded Cloud Pharmaceuticals in
2009. Addison is a serial entrepreneur who founded three previous ventures, two of which successfully merged with public companies. He has a unique and strong blend of in-depth business and technical experience in biotechnology
and in information technology. Addison holds an MS in Biomedical Engineering from Johns Hopkins University and MBA from Duke University Fuqua School of Business, including a diploma in Duke’s Health Sector Management Program.
From 2000-2009, Addison focused on a series of ventures in the pharmaceutical and life sciences space. These included start-ups in the life sciences market, including BioFortis, a LIMS venture in Baltimore, and Inclinix, a CRO
in Wilmington, NC, and TeraDisc, the predecessor of Cloud Pharmaceuticals, where he was named "Coastal Entrepreneur of the Year" in 2009. Addison has been working in drug discovery and development for over 12 years. As a life sciences
business development professional, he has negotiated numerous licenses for therapeutics and technology. He spent the early part of his career in information technology.
Addison has been an adjunct professor for over 25 years.
Previously he taught at Johns Hopkins University where he developed courses in bioinformatics and entrepreneurship. He was the co-founder and program director of the online MS degree in Bioinformatics for Johns Hopkins University's
Whiting School. Addison received prior awards for entrepreneurship including "Entrepreneur of the Year" in 1994 by the Information Industry Association, and #51 on the National Fast 500, and Coastal Entrepreneur of the Year in
2009. He is the author of a book called Leveraging the Horizon
about seed-stage technology ventures.
|Slava Akmaev, PhD||BERG LLC||AI in Pharma|
Senior VP & Chief Analytics Officer
Slava Akmaev, PhD, is the SVP and Chief
Analytics Officer at BERG. He heads the BERG Analytics business division and is the chief architect of Bayesian Artificial Intelligence software, bAIcis®. Dr. Akmaev is an avid advocate for data driven research and promotes
wider utility of advanced mathematical modeling techniques in pharmaceutical and clinical research. Dr. Akmaev has published numerous peer-reviewed manuscripts in genomics, systems biology, biochemistry and human genetics.
|Navid Alipour||Analytics Ventures||AI in Healthcare|
Co-Founder and Managing Partner
is Co-founder and managing partner at Analytics Ventures, a global venture studio providing end to end infrastructure to ideate, plan, form, launch, fund and validate brand new ventures in Artificial Intelligence. Navid has co-founded
and invested in multiple AI based companies including CureMetrix and CureMatch. He looks to identify top tier scientists, academics or corporate partners, and then to work with them to turn their R&D into viable businesses.
Navid serves on the board of Tech San Diego, helping develop San Diego's now thriving eco-system. He also serves on the boards of CureMetrix, AV Lab, Kazuhm, AlphaTrAI & AdTheos. He has been a panelist, judge, speaker or moderator
at forums such as UCSD, USD, SDSU, CyberHive, HeraHub, MIT Forum, RSNA, U.S. News STEM Conference, and CONNECT. Navid holds a BA from UC San Diego, and a JD/MBA from the University of San Diego.
|Heather Ames Versace, PhD||Neurala||Emerging Technologies and the Future of AI|
COO and Co-Founder
Ames Versace is Neurala’s co-founder and Chief Operating Officer. As COO, she contributes diverse executive skills ranging from oversight of multi-million dollar applied research initiatives, strategic planning, product management,
and leading translation of research into commercial products. Heather has spoken at TechCrunch and Forrester and was honored at the Google headquarters as being one of the Top 10 Women in Cloud emerging technology. Heather has
served as the Executive Director of the NSF-sponsored CELEST Science of Learning Center at Boston University. She holds a PhD in Cognitive and Neural Systems from Boston University and a BS in Cognitive Neuroscience from the University
of California at Berkeley, making her one of the few C-level executives in artificial intelligence with a technical degree.
|Katherine Andriole, PhD||Harvard Medical School||AI in Healthcare|
Director of Research Strategy and Operations, MGH & BWH Center for Clinical Data Science; Associate Professor of Radiology
Dr. Andriole is an Associate Professor of Radiology at Harvard Medical School, Brigham and Women’s Hospital, and was recently named the Director of Research Strategy and Operations at the MGH & BWH Center for Clinical
Data Science (CCDS) (www.ccds.io
). She studied Biomedical Engineering, and Electrical Engineering and Medicine at Duke University and Yale University, respectively, and did postdoctoral fellowships
at the University of California at Los Angeles, and the University of California at San Francisco (UCSF) Departments of Radiology. At UCSF, Dr. Andriole was instrumental in designing, building and implementing picture archiving
and communication systems (PACS) before they became commercial entities. Her research has involved technical as well as clinically-relevant developments in medical informatics, PACS, digital radiography, image processing and analysis,
business analytics, and machine learning. Dr. Andriole has developed and taught several formal courses, directed fellowships in biomedical imaging and informatics, and mentored more than 70 trainees. She has served in multiple
leadership roles for the Society of Imaging Informatics in Medicine (SIIM), currently serves on the Radiological Society of North America (RSNA) Radiology Informatics Committee and the RSNA Machine Learning Steering Committee,
and is the Senior Scientist for Education at the American College of Radiology (ACR) Data Science Institute. She is an Associate Editor of the Journal of Digital Imaging and the Journal of Medical Imaging. Dr. Andriole has been
elected a member of the Academy of Harvard Medical School, inducted into the College of SIIM Fellows, and named Second Vice President of the RSNA.
|Yindalon Aphinyanaphongs, PhD||NYU Langone Medical Center||Plenary Tuesday|
Yindalon Aphinyanaphongs, MD, PhD is an MD/ PhD in the Center for Healthcare Innovation and Delivery Science at NYU Langone Medical Center. Academically he is an assistant professor and his lab focuses on novel applications of
machine learning to clinical problems and research and infrastructure regarding model deployment and maintenance. He is also the Director of the Clinical Informatics Training program and helps to design curriculum for training
of our students to meet the needs of future employers. Operationally, he is the Director of Clinical Predictive Analytics and the Director of the Clinical Translational Data Science. In this role, he leads a Predictive Analytics
Unit that builds, evaluates, benchmarks, and deploys predictive algorithms into the clinical enterprise from his lab, the published literature, and industry.
|Steve Ardire||AI Startup Advisor||Cognitive Computing|
AI Startup Advisor & ‘Merchant of Light’
Steve Ardire is an Advisor to AI startups (50 software startups over 20 years) in business strategy, funding, go-to-market, customer/partner engagement shaping serendipity to connect and illuminate the dots that matter (aka ‘Merchant
of Light”) with clarity, conviction, passion to drive business model to success. Steve is an active speaker at AI events, does podcasts, webinars, interviews, presentations.
|Dave Arnette||NetApp||AI in Pharma|
Senior Solution Architect
David Arnette is a Sr. Solution Architect focused on Netapp solutions for AI and ML workloads. He has published numerous reference
architectures for enterprise applications on the FlexPod converged infrastructure and has over 18 years’ experience designing and implementing datacenter storage and infrastructure solutions.
|Sandy Aronson||Partners HealthCare Personalized Medicine||AI in Healthcare|
Executive Director of IT
Sandy Aronson is the
Executive Director of IT for Partners HealthCare Personalized Medicine. His team develops IT infrastructure required to support the evolution and practice of genetic based personalized medicine in both patient facing and laboratory
settings. The system ecosystem the team maintains enables a real time continuous learning process. These processes allows laboratories to harnesses their clinical testing flows to advance knowledge surrounding genetic variation
and the deliver this knowledge in near real time to clinicians treating patients. The team is also developing the Health Innovation Platform (HIP) to facilitate the introduction of app based IT interventions into the electronic
health record ecosystem. Mr. Aronson is one of the founders of GeneInsight. Prior to his work at Partners HealthCare, Mr. Aronson also held several positions with Sapient Corporation, was a Monitor Company consultant and founded
LearningAction. Mr. Aronson holds a Masters in Organizational Behavior and a Bachelors in Computer Science from Stanford University. He also received a Masters in Biology from Harvard Extension School.
|Saliha Azzam, PhD||Microsoft||SEMINAR - Building AI-powered Natural Language Solutions|
|John Baldoni||GlaxoSmithKline||AI in Pharma|
Senior Vice President, In silico Drug Discovery
Baldoni, PhD has over 30 years’ experience in the pharmaceutical industry and has held numerous senior executive positions at GSK including Senior Vice President and Global Head of Platform Technology and Sciences (PTS).
PTS is a global organisation that is responsible for the development, validation and delivery of key platform technologies in R&D. John has been instrumental in driving innovative thinking in GSK and recently proposed the creation
of and now leads an in-silico drug discovery unit in GSK. John is also the founder and co-chairman of the Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium -- a public private partnership open to other organizations
– currently comprised of GSK, Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, and the University of California, San Francisco. Its mission is to aid in transforming drug discovery
by accelerating the development of more effective therapies for patients.
|Janet Bannister||Real Ventures||AI Startup Pavilion|
Janet is a
Partner at Real Ventures, a leading source of capital for Canada’s game-changing entrepreneurs and a driving force behind emerging tech ecosystems. Janet has led investments in over a dozen companies and works actively with
founders to help them build large, industry-defining companies. In 2004, Janet launched Kijiji.ca and grew it to become one of the most visited websites in Canada. Subsequently, she led the Kijiji Global business, launching the
site in new countries and accelerating growth in North America, Europe, and Asia. Janet also spent four years at eBay in Silicon Valley where she helped transform eBay from a collectibles to a mainstream marketplace. Janet started
her career as a Brand Manager at Procter & Gamble and then joined McKinsey & Co. where she was an Engagement Manager. She also founded and built a successful consulting business and was CEO at a venture-backed start-up
prior to joining Real Ventures. Janet was a varsity long-distance runner and competed internationally in triathlons. Today she balances her active lifestyle with being a wife and mother to her 13 year-old son.
|Upal Basu||NGP Capital||AI Startup Pavilion|
Upal has worked in the mobile
and software technology industry for over 20 years. At NGP Capital, Upal leads the global Connected Enterprise investing theme, where he focuses on mobile enterprise and Internet of Things investments. In addition he is responsible
for managing NGP’s investments in India. Prior to NGP, he was Founder and CEO of Mformation Technologies, the world’s largest mobile device management company, which was acquired by Alcatel-Lucent. Previously he was
a management consultant for McKinsey & Company in New York and London. Prior to joining McKinsey, Upal led Product Management activities for Risk Management Solutions (RMS), a leading provider of software technologies for the
management of insurance risks. Upal has an MBA from Harvard Business School, an MS in Engineering from Stanford University, and a Bachelor’s degree in Engineering from Imperial College, London.
|William Beaudin||DDN Storage||Emerging Technologies and the Future of AI|
Director, Engineering; Solution Architect
Bio coming soon.
|Suzanne Belinson, PhD||Blue Cross Blue Shield Association||AI in Healthcare|
Executive Director, Clinical Markets, Office of Clinical Affairs
|Bryan Bell||Expert System||AI Technology Solutions Theater|
Executive Vice President
is responsible for delivering the Expert System artificial intelligence software solution to the financial services industry. He has extensive software industry experience helping build organizations focused on enterprise search,
taxonomy creation, and knowledge management platforms that are built using keywords, statistics, linguistics, semantics and artificial intelligence technology approaches.
|Jay Bellissimo||IBM Services||Plenary Session|
Managing Partner, Cognitive Process Transformation
Jay Bellissimo is the Global
Managing Partner of IBM Services Cognitive Process Transformation Growth Platform, leading the service lines of Cognitive Process Re-engineering, Cognitive Process Services, and Cognitive Business Decision Support. The Practices
he oversees include Watson AI & Data Platform, Advance Analytics, Blockchain, Watson Internet of Things, Watson Health, Talent & Engagement, Process Automation, among others. His primary mission is to fuel growth by deploying
competitive market offerings and building a diverse and differentiated talent pool and to continue to amaze and delight our customers. Previously, he was the General Manager and Chief Revenue Officer of the Watson & Cloud Platform.
He was responsible for the go-to-market strategy across IBM’s core cognitive and cloud-based technologies, including large transformation engagements, ecosystem/channels, business partners, and major client engagements. Jay’s
mission was to ensure that both Watson & Cloud Platform offerings resonate with customers and the overall market as they significantly grew market share. Jay has held multiple executive positons, such as General Manager, IBM
Cognitive & Watson Solutions, leading the customer engagement and product strategy for IBM’s portfolio of cognitive-based solution technologies across 18 industries; General Manager, Customer Experience for IBM Watson,
initiating the first wave of cognitive computing commercialization in key industries - healthcare, public sector, financial services - adopted by 36 countries in 5 different languages; Leader of IBM’s Global SAP Consulting
Business, managing the strategy, sales, client relationships, and operations; Leader IBM’s Global and North America Business Services Communications sector, which included the Media and Entertainment, Telco, and Energy/Utilities
industries; and lastly Leader of IBM’s Global Business Services in Latin America based in Sao Paulo, Brazil. Jay joined IBM in 1991 from PwC, holding numerous industry management and practice leadership positions, including
industry leadership roles in Chemicals & Petroleum, Industrial Products and Aerospace & Defense. Jay is a member of IBM’s Performance Team and Acceleration Team, both of which focus on the company’s short- and
long-term strategies for growth. Jay holds a B.A. in Political Science from St. Michael’s College. Jay serves as a member of Board of Trustees at St. Michael’s College and on Advisory Board of the Center of Innovation
& Entrepreneurship at Claremont McKenna College.
|Dimitris Bertsimas, PhD||MIT||Seminar: AI in Personalized Medicine and Digital Health|
Operations Research Center and Sloan School of Management
is currently the Boeing Professor of Operations Research and the co-director of the Operations Research Center at the Massachusetts Institute of Technology. He has received a BS in Electrical Engineering and Computer Science at
the National Technical University of Athens, Greece in 1985, a MS in Operations Research at MIT in 1987, and a Ph.D in Applied Mathematics and Operations Research at MIT in 1988. Since 1988, he has been with the MIT faculty. Since
the 1990s he has started several successful companies in the areas of financial services, asset management, health care, publishing, analytics and aviation.
His current research interests include personalized medicine, analytics,
machine learning and robust and adaptive optimization.
He has co-authored more than 200 scientific papers and four textbooks, including the book "The Analytics Edge" published in 2016. He is the current editor in Chief of
the INFORMS journal of Optimization and a former area editor in Operations Research in Financial Engineering and in Management Science in Optimization. He has supervised 63 doctoral students and he is currently supervising 20 others.
He is a member of the US National Academy of Engineering, and an INFORMS fellow. He has received several research awards including the Philip Morse lectureship award (2013), the William Pierskalla award for best paper in health
care (2013), the best paper award in Transportation Science (2013), the Farkas prize (2008), the Erlang prize (1996), the SIAM prize in optimization (1996), the Bodossaki prize (1998) and the Presidential Young Investigator award
|Paul Blase||Speciate AI||AI Technology Solutions Theater|
Blase is CEO of Speciate AI. Formerly Paul led PwC’s U.S. and global analytics advisory practice which included 1,700 practitioners and a portfolio of analytics solutions sold to PwC clients. Paul holds an M.B.A from M.I.T.
Sloan School of Management and a B.A. from Northwestern University.
|Russell Blattner||Lucd||AI Startup Pavilion|
CEO and Co-Founder
Russ Blattner has been helping Enterprises achieve their corporate
goals through technology transformations, starting with Networks, moving to Cloud and Big Data and now through Enterprise AI. Mr Blattner is leveraging his experience running large operations, driving sales, and product development.
He manages a team of world class Data Scientists, AI, ML/Machine Learning, Dynamic Learning, Deep Neural Networks, Big Data, Data Wranglers, Super Computing and the best Enterprise facing team one could hire.
|Paul Bleicher||OptumLabs||Plenary Session|
Paul Bleicher, MD, PhD, is the CEO of OptumLabs,
an open, collaborative research and innovation center established by Mayo Clinic and Optum to accelerate improvements in patient care and value through clinical, policy and product innovation driven by new insights from healthcare
big data. Previously, he was Chief Medical Officer for Humedica, a next-generation clinical informatics company. Before Humedica, Dr. Bleicher was a founder of, and spent 11 years building and guiding the growth of Phase Forward,
which led the transformation of pharmaceutical clinical trials from paper to the web, and was acquired by Oracle in 2010. He began his career as a dermatologist/researcher at Massachusetts General Hospital/Harvard Medical School,
and subsequently worked in clinical development in the biopharmaceutical industry.
Robert has built and supervises deepsense.ai’s
machine learning team. He focuses on bridging the gap between AI research and real-life business challenges. In addition to working with clients, Robert also leads deepsense.ai’s research and development team, managing and
supporting their efforts in deep learning and reinforcement learning. Apart from his business activities, Robert is also a university lecturer on machine learning and an award winning Kaggle competitor.
|Amélie Boichard, PharmD, PhD||UCSD Moores Cancer Center||Seminar: AI in Personalized Medicine and Digital Health|
Project Scientist, Center for Personalized Cancer Therapy
Amélie Boichard, Pharm.D., Ph.D., is a clinical biologist passionate for genetics and molecular pathology. She joined the Center for Personalized Cancer Therapy at Moores Cancer Center (La Jolla, California) as a post-doctoral
researcher in 2014, and later as a research scientist. Here, she participated in the creation of an algorithm-based therapeutic decision-support system, later licensed to the local start-up CureMatch, Inc., where she acts as Vice
President for Research and Clinical Affairs. Dr. Boichard is convinced that properly choosing optimized and personalized therapeutic regimens may drastically improve the survival and quality-of-life of cancer patients, and is the
future of oncology.
Before joining UC San Diego, Dr. Boichard received a multi-disciplinary training in pharmacy, human genetics, and oncology from Paris-Sud University and Paris-Descartes University (France), and completed
her residency in clinical pathology at Gustave Roussy Cancer Institute (Villejuif, France).
|Karim Botros||The MetroHealth System||AI in Healthcare|
Chief Strategy and Innovation Officer
is the Chief Strategy and Innovation Officer for The MetroHealth System overseeing business and corporate development, innovation, integration as well as planning and market research. He joined MetroHealth in 2013 as the Chief
Strategy Office and was the co-lead of the Adult Care and Wellness Service Line overseeing approximately 225 providers across adult care, express care, hospitalists, geriatrics, behavioral health and dental care between 2015 and
Prior to joining MetroHealth, Mr. Botros was a member of the Cleveland Clinic's Emerging Businesses group and oversaw corporate development projects. Between 1999 and 2008, he worked in private equity, acquiring companies
within the health care, IT, and business service industries at The Riverside Company and The Jordan Company. While at the Riverside Company, Mr. Botros led the Healthcare origination efforts for both the micro-cap and the capital
appreciation fund. Within the health care manufacturing industry, Mr. Botros has worked at Baxter Healthcare and Biomet as a manufacturing and product engineer. He received his MBA from Northwestern University's Kellogg School
of Management, and his master's in manufacturing engineering management and his BS in biomedical engineering from Northwestern University.
|Chris Bouton, PhD||Vyasa Analytics||AI in Pharma|
Dr. Bouton received his BA in Neuroscience
(Magna Cum Laude) from Amherst College in 1996 and his Ph.D. in Molecular Neurobiology from Johns Hopkins University in 2001. Dr. Bouton is the CEO of Vyasa Analytics, applying novel deep learning approaches for enterprise clients.
Previously Dr. Bouton was the CEO of Entagen a software company founded in 2008 that provided innovative Big Data products including Extera and TripleMap. Entagen's technologies won numerous awards including the "Innovative Technology
of the Year Award for Big Data" from the Massachusetts Technology Leadership Council in 2012 and Entagen was recognized as a Gartner "Cool Vendor" in the Life Sciences in 2013. Entagen was acquired by Thomson Reuters in 2013.
Prior to his role as the CEO of Entagen, Dr. Bouton worked as a computational biologist at LION Bioscience Research Inc. and Aveo Pharmaceuticals from 2001 and 2004, leading the microarray data analysis functions at both companies.
In 2004 he accepted the position of Head of Integrative Data Mining for Pﬁzer. While at Pfizer, Dr. Bouton conceived of and implemented an organization-wide knowledgebase called Pfizerpedia for which he won the 2007 William E.
Upjohn Award in Innovation. Dr. Bouton is an author on over a dozen scientific papers and book chapters and his work has been covered in a number of industry news articles.
|Jim Brase||Lawrence Livermore National Laboratory||AI in Pharma|
Chief Technical Officer & Interim Co-Lead, ATOM and Deputy Associate Director for Computation
Jim Brase is the Deputy Associate Director for Programs in the Computation Directorate at Lawrence Livermore National Laboratory (LLNL). He leads LLNL research in the application of high-performance computing, large-scale data
science, and simulation to national security missions. Jim’s research interests focus on the intersection of machine learning, simulation, and high-performance computing. He is currently leading efforts in the large-scale
computing for life science, biosecurity and nuclear security applications. In his previous position as LLNL’s Deputy Program Director for Intelligence Jim led efforts in intelligence and cybersecurity R&D. He was formerly
LLNL’s Division Leader for Optical Sciences and led programs in laser and imaging research at LLNL. Jim received a B.S. in Electrical Engineering from Iowa State University, and an M.S. in Electrical and Computer Engineering
from University of California, Davis.
|David Bray, PhD||Institute for Human-Machine Cognition||Plenary Session|
Executive Director, People-Centered Internet Coalition, Senior Fellow
Dr. David A. Bray was named one of the top “24 Americans Who Are Changing the World” under 40 by Business Insider in 2016. He was also named a Young Global Leader by the World Economic Forum for 2016-2021. He was
named a Marshall Memorial Fellow and traveled to Europe to discuss Trans-Atlantic issues of common concern including exponential technologies and the global future ahead. Since 2017, he serves as Executive Director for the People-Centered
Internet coalition co-founded by Vint Cerf, focused on providing support and expertise for community-focused projects that measurably improve people’s lives using the internet. He also provides strategy to both Boards and
start-ups espousing human-centric principles to technology-enabled decision making in complex environments.
|Nick Brestoff||Intraspexion||Enterprise AI Strategies Theater|
I'm the founder and
CEO of Intraspexion Inc. By combining AI’s Deep Learning technology with the capabilities of dtSearch, Intraspexion offers the first patented Litigation Prevention service for Corporate Legal Departments. Our system filters
internal emails (from yesterday) for litigation risk, which enables investigations and prevention. I'm also the sole or lead inventor on Intraspexion's eight (8) Deep Learning patents, the 8th for using blockchain to enable deep
learning. When that patent issues, the only companies with more Deep Learning patents will be Google, IBM, Microsoft, and Siemens Healthcare.
|Amanda L. Brown||Innolegal Services, PLLC||Enterprise AI Strategies Theater|
Legal Innovation Advisor + Counsel
Combining her substantive legal skills with her technical know-how, Amanda has been a key contributor to several legal innovation and technology projects. Most recently, she served as the inaugural Microsoft NextGen Fellow with
the American Bar Association Center for Innovation. Throughout her fellowship, she played important roles in several cutting-edge contracting and legal-focused artificial intelligence projects – from data selection and training,
to model validation. During her fellowship, Amanda also had the opportunity to research and devise a number of policies for the development and implementation of artificial intelligence projects. From a consumer perspective, Amanda
evaluated and proposed mitigation strategies to novel legal issues, such as the ethical obligation to disclose user interaction with AI systems. She also worked diligently with an in-house team to identify a framework by which
engineers can reduce the introduction of human biases in the artificial intelligence development lifecycle. Moreover, she worked closely with cross-disciplinary teams to support the design and development of the Legal Services
Corporation’s Statewide Access to Justice Portal Project, among a number of other innovative projects.
|Ed Burns||TechTarget||AI and Real-Time IoT|
manages editorial content and writes about AI, machine learning, deep learning and related technologies for SearchEnterpriseAI. Prior to joining the site, he covered business intelligence, analytics and data visualization as a
senior news writer for SearchBusinessAnalytics; before that, he was a reporter for SearchHealthIT, writing news stories on federal electronic health record policy, health information exchanges and emerging health IT-related business
practices. Ed began building his reporting experience while earning a master's degree in journalism from Emerson College. His work has also been published in a number of daily and weekly newspapers throughout eastern Massachusetts,
including the Lowell Sun, Westwood Press and Roslindale Transcript.
|Matthew Carroll||Immuta||Emerging Technologies and the Future of AI|
Matthew Carroll, president and CEO of Immuta,
is responsible for the growth and direction of the company. Prior to co-founding Immuta, Matt spent a decade analyzing the world's most complex datasets while supporting multiple US Intelligence Community customers. He also served
as CTO of CSC’s Defense & Intelligence Group, leading critical data fusion and analytics programs ($150M in revenue) while advising US Government leaders on data management and analytics issues.
|Christopher Carothers, PhD||Lucd||Enterprise AI Strategies Theater|
Technology & Academic Advisor, Research & Development
Chris Carothers, Ph.D is an Advisor to Lucd.ai. His simulation research involves the creation of high-fidelity models of extreme-scale wireless and wired networks and computer systems. These models have executed using nearly
2,000,000 processing cores on the largest leadership class supercomputers in the world. He has secured over $10 million in research funding from agencies including the NSF, the U.S. Department of Energy, Army Research Laboratory,
Air Force Research Laboratory, IBM, General Electric, and AT&T.
|Jie Cheng, PhD||Abbvie||Seminar: AI in Personalized Medicine and Digital Health|
Associate Director, Data & Statistical Sciences
Jie Cheng received his Ph.D. in Computer Science in 1998 and completed his postdoctoral training in AI & Machine Learning in 2000. He has more than 15 years of experience in applying machine learning and predictive modeling
to clinical and biomarker data analysis. He has won several data mining competitions including KDD-cup and FDA led MicroArray Quality Control data analysis. Dr. Cheng is an associate director at Abbvie, leading biomarker and exploratory
analysis in immunology and neuroscience projects.
|Wei-Yi Cheng, PhD||Roche||Seminar: AI in Personalized Medicine and Digital Health|
Senior Data Scientist
Wei-Yi Cheng is a senior data
scientist at Roche Innovation Center New York. He specialized in integrated big data analytics with a focus on digital biomarker development for neurological diseases, and genomics biomarker discovery. He is one of the global driving
forces in Roche to identify areas where advanced analytics can bring value to pharmaceutical R&D.
|Carolyn Cho, PhD||Merck||AI in Pharma|
Director, Immunology Therapeutic Area Pharmacometrics Lead
Carolyn has worked in the pharmaceutical industry for 20 years, applying modeling and systems biology approaches to decision making across the research and development pipeline, from validating targets to registering new therapeutic
agents. She serves on the Board of Trustees of the Mathematical Biosciences Institute at the Ohio State University, and previously on the boards of ventures including North Atlantic BioPharma Inc., Research Avenue Inc., and Research
Propel Careers. She currently oversees modeling across the immunology pipeline at MRL, and has previously led the Systems Biology Targets group at Pfizer, was Global Head of Computational Systems Biology at Novartis Institutes
for Biomedical Research (NIBR), and has held positions at Physiome Sciences (Princeton, NJ), SmithKline Beecham Pharmaceuticals (King of Prussia, PA), and Princeton University. Carolyn received her Ph.D. in biological physics from
the University of Toronto.
|Danielle Ciofani||Broad Institute of MIT and Harvard||Seminar: AI in Personalized Medicine and Digital Health|
Director of Data Strategy and Alliances
leads the Broad Institute’s Data Sciences Platform team in creating software and machine learning algorithms that maximize the impact of data science in biomedicine. In addition to her role at Broad, she serves the digital
health startup community as an Executive in Residence for .406 Ventures.
|David Colarusso, PhD||Suffolk University||Going from Big Data to AI|
|Jonathan Dahlberg||Real Ventures||AI Technology Solutions Theater|
Jonathan is a customer facing data scientist at DataRobot, working across industries like finance, healthcare, and oil & gas. He recently spent a stint in Australia expanding DataRobot’s Australian market, and has degrees
in Mathematics and Economics from Williams College.
|Mark Davies||Benevolent AI||AI in Pharma|
Vice President Biomedical Informatics
Mark is the
VP Biomedical Informatics at BenevolentAI, where leads the informatics activities for the company. He has a background in molecular genetics, bioinformatics (BSc University of Sussex) and computer science (MSc Birkbeck College)
and has over 15 years of experience working on biomedical data representation, data analysis and application development. In 2001, he joined the London based biotechnology company Inpharmatica, where he was initially working on
mining the output of the Human Genome Project and eventually moved on to building chemogenomics and druggability assessment systems used by pharmaceutical companies, such as Bayer. Mark moved to the European Bioinformatics Institute
(EMBL-EBI), as one of the founding members and technical lead for the ChEMBL database, the largest open-source Structure Activity Relationship (SAR) database. Mark was also responsible for the successful transition of the SureChEMBL
chemical patent system from Digital Science to the EMBL-EBI.
|Boyd Davis||Accenture||Going from Big Data to AI|
Managing Director, Applied Intelligence
|John Desmond||AI Trends|
Featured Author, AI Trends As Editorial Director, John engages with industry experts who focus on the critical business and technology implications of artificial intelligence. John has more than 20 years experience as editor
and writer for business and technology publications. He has worked at IDG (Computerworld), Sentry Publishing (Software Magazine), SPG (Application Development Trends), SIGS Publications (Object Magazine, Component Strategies, Java
Report, Journal of Object Oriented Programming), JupiterMedia (esecurityplanet.com) and others. John acquired Software Magazine and subsequently sold it to Rockport Publishing. In conference content development, John has developed
programs for several events, including Enterprise Linux Forum, Enterprise Wireless Forum, Software Marketing Perspectives and now AI World.
|Adam Devine||WorkFusion||Implementing Enterprise AI|
Senior Vice President Marketing and Chief Evangelist
|Wael William Diab||Industrial Internet Consortium; Huawei||AI and Real-Time IoT|
|Matt Doherty||RESOLUTE.AI||AI Startup Pavilion|
|Jonathan Dry, PhD||AstraZeneca||AI in Pharma|
Director of Bioinformatics, Oncology
studied Biomedical Sciences at the University of Manchester where his research focused on the genetics of diabetes, exposing him to the richness of information in DNA that can be uncovered with computational tools. He was awarded
a scholarship at the University of Exeter to study Bioinformatics, where he collaborated with GlaxoSmithKline to develop computational models determining the risk of recombinant protein breakdown by proteases in host cells. In
2003 Jonathan joined AstraZeneca as the first member of the newly formed Oncology Bioinformatics team. As a scientist and senior scientist he drove adoption of ‘omic data to establish molecular line of sight for new targets,
specializing in gene expression microarrays. He introduced a number of pioneering approaches harnessing gene expression data from cancer cell lines to uncover the mechanisms of pathway/drug target dependency, discovering biomarkers
of drug response. Throughout his career he has supported and influenced a number of programs, including drugs targeting PARP (Lynparza), mTOR, PI3K, AKT and ERBB. His work for the MEK inhibitor selumetinib led to a transcriptional
readout of MEK activity that became the first transcriptomic hypothesis tested in AZ clinical trials. Jonathan carries a strong collaborative attitude and is a champion of open innovation to harness the world’s data and expertise
for actionable discovery. As a team leader and now Director of oncology bioinformatics, and a leader of AZ’s strategy to harness AI for discovery, Jonathan has gone on to build a global group focused on harnessing next generation
sequencing and genomic data to further AstraZeneca’s oncology drug programs and precision medicine. His team are recognized as leaders in the field, with a number of high profile publications and algorithms now adopted by
leading research centers around the world such as the VarDict NGS variant caller.
|Phil Duffy||Brain Corp||SEMINAR: State of the Technology: Making Robots Intelligent, Cognitive and Aware|
Vice President of Innovation
|Lynne Dunbrack||IDC Health Insights||Executive Summit|
Research Vice President
Lynne Dunbrack is Research Vice President for IDC Health Insights responsible for the research operations for IDC Health Insights. She manages a group of analysts who provide research-based advisory and consulting services for
payers, providers, accountable care organizations, IT service providers, and the IT suppliers that serve those markets. Lynne also leads the IDC Health Insights' Connected Health IT Strategies program. Specific areas of Lynne's
in-depth coverage include mobile, constituency engagement, interoperability, health information exchange, privacy, and security. Technology coverage areas include clinical mobility (physician facing) and mobile health (consumer
facing), health information exchange, end-to-end remote patient health monitoring for health , wellness and chronic conditions, Internet of Things (IoT), personal health records and member, patient, provider portals, kiosks, videoconferencing
and online care, unified communications, aging in place, and social.
|Venkatanathan Dwarkanathan, PhD||AntWorks||AI Startup Pavilion and Theater Presentations|
Dr. Venkatanathan Dwarkanathan is an accomplished Mathematician with active engagement in research on topics like Chaos theory, fractal based pattern recognition
and several others in applied mathematics, including dyna-systems theory, Fractal compositions and geophysical image dynamics. Prior to joining AntWorks, Dr. Venkatanathan Dwarkanathan held a broad range of leadership positions
in mission critical portfolios in large organizations like National Aeronautics and Space Administration, Boeing, Aetna, Ausys Automation, Maples and iData Sciences. He holds a Ph.D. degree in Mathematics (Astro-pad dynamics) and
a post-doctoral work in Fractal Topology with profound expertise in building software frameworks which generates math models for applications in various verticals. During the past 25+ years, he has developed many theories and built
models for different verticals including; Aerospace (Image Sequencing), Roadways (Crack detection in JPEG images),Market Intelligence (Fractal Genesis), Healthcare (Mathematical Models for payers) and generic Data Capture Framework
using Content Based Object Retrieval Methods.
|Jana Eggers||Nara Logics||Cognitive Computing|
|Lance Eliot, PhD|
- Techbrium, Inc.
- AI Trends Insider
Dr. Lance Eliot, AI Trends Insider, CEO,
Techbrium Dr. Lance B. Eliot, MBA, PhD, is a serial entrepreneur, having launched, run, and sold three high-tech businesses, and currently serves as CEO of Techbrium Inc. He also serves as the Executive Director of the Cybernetic
Self-Driving Car Institute. You can meet Lance at AI World 2018 where he is keynoting on driverless cars. He is currently a regular contributor as our AI Trends Insider, where he has recently authored over 160 articles and has
published 11 books on the future of driverless cars.
|Ernie Feiteira||Liberty Mutual ||Emerging Technologies and the Future of AI|
Manager of Strategy & Innovation
|Susan Feldman||Cognitive Computing Consortium||Cognitive Computing|
|Sheldon Fernandez||DarwinAI||Emerging Technologies & the Future of AI|
CEO of DarwinAI, is a seasoned executive and respected thought leader in the technical and enterprise communities. Throughout his career, he has applied emerging technologies such as Artificial Intelligence to practical scenarios
for enterprise clients. Sheldon is also an accomplished author and speaker. He has spoken at numerous conferences in numerous contexts, including Singularity University, the prestigious think tank in the Bay Area, and has written
technical books and articles on many topics including both Artificial Intelligence and Computational Creativity. Through his career, Sheldon has coupled his entrepreneurial endeavors and engineering exploits with non-technical
pursuits. He completed a Master’s degree in theology at the University of Toronto in 2008. He also pursued creative writing at Oxford University, and finally, completed a professional training program at the Montreal Institute
for Genocide Studies in Mass Atrocity prevention.
|Sanji Fernando||OptumLabs||Going from Big Data to AI|
Sanji is a Vice President and Head of the OptumLabs Center
for Applied Data Science (CADS). CADS focuses on the application of new data science methods to solve complex health care challenges, applying breakthrough innovations in Artificial Intelligence and Machine Learning to create software
Sanji joined UnitedHealth Group in 2014 from Nokia, where he created the Data Science team for Nokia. The Data Science team was responsible for launching the first big data computing cluster at Nokia to analyze user activity
and engagement and design new product concepts from the insights generated from this cluster. Before that, Sanji spent 9 years at Nokia in a variety of corporate roles with Nokia’s Advanced Business Development team, Nokia
Research and Nokia Ventures.
Prior to Nokia, Sanji was a co-founder and VP of Engineering of a venture-backed mobile software company, Vettro. Sanji began his career in consulting with Viant and Accenture.
Sanji is a
graduate of the Trinity College with a bachelor’s degree in Computer Science.
|Balazs Flink, MD||Bristol-Myers Squibb||AI in Pharma|
Clinical Trial Analytics Lead, R&D Business Insights and Analytics
Balazs is a key R&D contributor to the company’s efforts to integrate analytics, strategy and insights capabilities to drive key decisions that generate greater outcomes for patients. His team provides predictive analytics,
clinical trial feasibility and forecasting capabilities together with tracking, benchmarking and metrics generation for the R&D organization. Graduated as a physician, explored medicine from the academic perspective before
he joined BMS in 2005. Balazs held roles of different functions in R&D before taking over the leadership of the Clinical Trial Analytics group in the newly formed Business Insights and Analytics organization in February 2016.
His main goal in this new integrated analytics organization is to establish common consciousness in R&D and to connect strategy and execution through data and insights.
|Jim Freeze||Interactions||Keynote Breakfast Presentation|
Chief Marketing Officer
Bio coming soon.
|Walter Frick||Harvard Business Review||Plenary Session|
|Joseph Fung||Kiite||SEMINAR - Building AI-powered Natural Language Solutions|
|Tsvi Gal||Morgan Stanley||Plenary Session|
Tsvi Gal is a Managing Director and
CTO of Enterprise Infrastructure at Morgan Stanley. Tsvi has over 25 years of technology and operations experience mostly in financial services global corporations.
Tsvi’s career included work as CTO and CIO in several
banks including Merrill Lynch/Bank of America, Deutsche Bank and Wells Fargo as well as in non-banks including general partner of a private equity firm, president of AT&T.com and CIO of Time Warner Music.
|Ryan Gariepy||ClearPath Robotics||AI Technology Solutions Theater|
|Nathaniel Gates||Alegion||Plenary Session|
Nathaniel Gates is co-founder and CEO of AI accelerator firm Alegion, a provider
of ground truth training data for machine learning initiatives. Prior to Alegion, he founded Cloud49, a successful cloud-computing solutions provider focused on the public sector. Nathaniel has a passion for evolving and enriching
the global on-demand workplace. Nathaniel lived and worked in Alaska for 36 years prior to moving with his family to the much warmer climate of Austin, TX in 2012.
|Ilya Gelfenbeyn||Google||AI Startup Pavilion|
Head of Google Assistant Investments
|Madhavi Gidh-Jain, PhD||Sanofi||AI in Pharma|
Senior Director, Head Medical Writing, Clinical Documentation
Twenty years medical writing experience in the pharmaceutical industry. Extensive managerial experience of medical writers across global locations. Worked as lead writer on numerous Health Authority submissions.
|Inmar Givoni, PhD||Uber ATG||Plenary Session|
Machine Learning at University of Toronto, Autonomy Engineering Manager
Inmar Givoni is a Senior Engineering Manager at Uber ATG, Toronto, where she leads a team whose mission is to bring from research and into production cutting-edge AI for self-driving vehicles. She received her PhD (Computer Science)
in 2011 from the University of Toronto, specializing in machine learning, and was a visiting scholar at the University of Cambridge. She worked at Microsoft Research, Intel, and Toronto startups at roles ranging from research scientist
to VP of Big Data, applying AI to various problem domains from eReading to Robotics. She is an inventor of several patents and has authored numerous top-tier academic publications in the areas of machine learning, computer vision,
and computational biology. She is a regular speaker at AI events, and is particularly interested in outreach activities for young women, encouraging them to choose technical career paths. For her volunteering efforts she was recognized
as one of Canada’s 50 inspiring women in STEM
|Pawel Godula||deepsense.ai||Seminar: Enterprise Machine Learning & Deep Learning|
Director of Customer Analytics
Paweł oversees machine
learning solutions focused on customer behavior and predictive modelling including demand forecasting, predictive maintenance and risk modelling. Prior to his current position he headed BCG Gamma’s office in Warsaw and a
Chief Data Scientist at Netsprint group (one of the largest data ecosystems in Poland).
|Jonathan Gordon||NYP Ventures at New York-Presbyterian||AI in Healthcare|
Jonathan Gordon is Director of NYP Ventures, the strategic
venture capital arm of NewYork-Presbyterian, where he is responsible for managing the hospital’s venture investment fund, building strategic partnerships, and managing the hospital’s IP portfolio. Previously, Jon was
a Director in NYP’s Office of Strategy, where he worked on projects ranging from launching the hospital’s Medicare accountable care organization to building a telehealth program. Jon is also Director of the Health Policy
Center at New York-Presbyterian, which advocates for the role of Academic Health Centers in developing solutions for the American health care system. Jon serves on faculty at Weill Cornell Medicine and both teaches about leading
healthcare transformation and directs the EMBA capstone program.
Prior to joining NYP, Jon helped found and served as Chief Operating Officer of EveryDay Medical, an e-commerce-based provider of durable medical equipment.
Jon is a board member for NYCEDC’s Digital Health Breakthrough Network, a Director of Costs of Care, a not-for-profit dedicated to increasing cost awareness among clinicians, and a Mentor for the German Accelerator and Blueprint
Health incubator. Jon holds a BA cum laude from Princeton University and an MBA with honors from Columbia Business School.
|Francis Govers III||Bell Helicopter||Implementing Enterprise AI|
Govers is the designer of over 25 unmanned land, sea, air and space vehicles and is an expert in robotics and autonomy. He currently works at Bell Helicopter as autonomy lead for large UAVs. He is an Air Force veteran, spent 10
years at NASA, was head of control for the International Space Station, was deputy Chief Engineer for the US Army Future Combat Systems, and participated in the DARPA Grand Challenge. He received five outstanding achievement awards
from NASA, the Pioneer Award by the National Space Society, and recognition from Scientific American for “World Changing Ideas”.
|Munish Goyal||IBM||Workshop: Deploying and Scaling Enterprise AI Systems|
Chief Data Scientist & Assoc. Partner
|Dany De Grave||Sanofi||AI in Pharma|
Senior Director, Innovation Programs and External Networks
Dany currently leads the implementation of various cognitive and other innovative technologies in departments like R&D and Regulatory Intelligence. NLP, machine learning, and advanced analytics are used to further our understanding
of diseases and vaccination mechanisms, as well as the regulatory landscape. He also explores blockchain applications.
Dany is an engineer trained in biology and has over 20 years of industry experience at leading global vaccine
companies GSK and Sanofi Pasteur. In various positions he contributed to the research, development, manufacturing and regulatory submission of both companies’ line of vaccines. Next to vaccine and automation projects he developed
and lead forward-looking change initiatives like “Project M: An Experiment in New Ways of Working, Inspiring Engagement, and Unleashing Talents” for which the team received multiple international awards.
|Steve Grobman||McAfee||Plenary Session|
Senior Vice President, Chief Technology Officer
Grobman is SVP and CTO for McAfee. He sets the technical strategy and direction to create technologies which protect smart, connected computing devices and infrastructure worldwide. He drives McAfee innovation and leads thousands
of technical resources to deliver robust and sophisticated cybersecurity solutions that protect corporate and consumer assets. Grobman came to McAfee from Intel where he spent over two decades in senior technical leadership positions
related to cybersecurity. He has published multiple technical papers and books, holds 24 U.S. and international patents in the fields of security, software, and computer architecture, with another roughly 20 patents pending. Grobman
earned his bachelor's degree in computer science from North Carolina State University.
|Jeremy Gu||Uber||Strategic Business Functions and AI|
Senior Data Scientist
Jeremy Gu is Senior Data Scientist
of Experimentation Platform at Uber, San Francisco. He is responsible for Autonomous Decision Systems for internal teams to optimize business campaigns. The system combines both concepts of machine learning models and statistical
experiments so that experimenters can optimize the business metrics while collecting data from statistical experiments.
Previously, Jeremy was Applied Machine Learning Scientist at Amazon, Seattle. He built a real-time bidding
algorithm and flash deals recommendation on the Automated Advertising team and managed the projects on sales leads generation, product cross-sells recommendation and customer's AWS use case prediction on the Amazon Web Services
Jeremy received an MS in Statistics from the University of Washington and a BS in Mathematics and Statistics from the University of Minnesota. Jeremy is also a member of the American Statistical Association
(ASA). He served as Chapter Vice President and Chapter Representative of ASA for three years.
|Basker Gummadi||Bayer||AI in Pharma|
Digital Innovation Lead
Basker is a great visionary
with a proven track record of driving innovation to enable strategic business objectives. He has vast experience in executing key strategic projects and cross-departmental programs across pharmaceutical research and development.
His current focus areas are as follows:
- Enabling innovation to drive new business models.
- Optimizing Clinical Trials with Block Chain, AI, Robotic Process Automation, and Big data.
- Leading a non-profit forum for digitalizing drug development and enabling precision medicine initiatives.
Basker is a resident of Somerset County, New Jersey and enjoys volleyball, cricket, volunteering his time in coaching, mentoring within the community, and serving Habitat for Humanity & Boy Scouts of America.
Head of Sustainability Campaign
Anju Gupta is currently the Head of Sustainability
Campaign for Syngenta. In her role, she will be responsible for managing the global social media analytics and campaign strategy for Syngenta. Prior to that, Anju led the corporate innovation at Monsanto. She and her team built
a unique digital partnership platform that rapidly enabled digitization and adoption of Artificial Intelligence at scale. Monsanto received CIO100 innovation award in 2018 for her work on “Innovating through Partners”.
Anju started her career at Monsanto as a statistical geneticist and transitioned into leading global analytical teams. As part of her career, she also successfully delivered long term strategies for Monsanto’s product portfolio.
Anju is a Science Fellow and selected as YWCA Women Leader in 2014. She is a frequent invited speaker on Artificial Intelligence in Silicon Valley & New York and has also co-authored a book “AI in Business” by John
Desmond. She serves as an Executive Board Member of AIWorld and NPower. Anju has a Ph.D in Quantitative Genetics from The Ohio State University and has 17 granted and published patents.
|Sharad Gupta||Blue Shield of California||AI in Healthcare|
Director of Enterprise Architecture
is a technology leader with extensive large-scale enterprise architecture strategy, technology strategy, IT roadmapping, solution architectures, and business solutions delivery background. He has led delivery of large-scale strategy
and implementation programs in matrixed environments, involving complex business processes, and diverse technologies. He has deep background in application architectures, data architectures, modern architectures, emerging technologies,
and digital transformations. Sharad is currently serving as the Director of Enterprise Architecture at Blue Shield of California and is responsible for the strategic direction, planning and delivery of enterprise architecture strategy,
multi-year implementation roadmaps, technology selection, and architectures for large business transformation initiatives. Sharad is also a lecturer at the University of California, Davis, Graduate School of Management in the Master
of Science in Business Analytics (MSBA) program. In this graduate level program, he is teaching the Data Design and Representation course that covers structured, semi-structured, unstructured) data design, relational & NoSQL
database architectures, machine learning for text analytics, and enterprise data management and analytics. Sharad has an MBA (Technology Management and Marketing) from the University of California, Davis, Graduate School of Management
and a BS in Computer Science.
|John Harrsen||Graphcore||Emerging Technologies and the Future of AI|
VP Cloud Product Management
|Wayne Hauber||Synergi Partners||Enterprise AI Strategies Theater|
Chief Innovation Officer
Haubner is Synergi Partners’ Chief Innovation Officer. Synergi Partners works closely with government agencies to ensure tax benefits are awarded to employers and helps meet the challenging needs of the community. Wayne’s
most recent work with Puerto Rico’s federal and local governments has assisted businesses of all sizes in their recovery from last year’s devastating Hurricanes Irma and Maria. Wayne believes that technology and innovation
can help ease the stress on businesses and drives his passion to seek out new ways to tame the diversity and volume of data available to government and commercial enterprises.
|Tom Hebner||Nuance Communications, Inc||AI in Healthcare|
World Wide Leader, Cognitive Innovation Group
|Peter Henstock, PhD||Pfizer||AI in Pharma|
AI & Machine Learning Lead
is a Senior Manager in the Business Technology group in Pfizer. His role as AI & Machine Learning Technical Leader is working to bring AI technologies across the company. He holds a Ph.D. in Artificial Intelligence along with
5 Master’s degrees. He also teaches graduate level AI, Machine Learning and Software Engineering at Harvard University.
|Sara Holoubek||Luminary Labs||AI in Pharma|
Sara Holoubek is the CEO and founder of Luminary
Labs, a consultancy that develops strategies and innovation systems to help Fortune 500, government, and nonprofit organizations thrive in the face of change. She is also an active early stage investor. Sara is particularly passionate
about the thorny problems that matter such as stemming chronic disease, closing the skills gap, rethinking the future of work, and using data to make smart cities safer.
Sara writes and speaks extensively on the intersection
of technology, innovation, and humanity. She has been recognized by LinkedIn as a 2017 Top Voice in Technology, Mashable as a female founder to watch, SmartCEO magazine as a 2017 New York Brava award winner, and PepsiCo WIN for
her contributions to women in technology. Sara holds a B.A. from the University of Iowa and an M.B.A. from HEC in France.
|Carl Horton||IBM||Workshop: Deploying and Scaling Enterprise AI Systems|
|Clare Gillan Huang||Babson College||Cognitive Computing|
Technology Operations and Information Management Lecturer
|Philip Hunter||Rethink||SEMINAR - Enterprise Machine Learning & Deep Learning|
|Judith Hurwitz||Hurwitz & Associates||Going from Big Data to AI|
President and CEO
Judith S. Hurwitz is president and CEO of the Hurwitz Group –
– a consulting, research and analysis firm focused on emerging technology including cognitive computing, artificial intelligence, advanced analytics, hybrid
cloud computing and management, software development and operations, and security and governance. She is an author, thought leader, technology strategist, and consultant. In 2015 Hurwitz coauthored Cognitive Computing and Big Data
Analytics (Wiley, 2015). A pioneer in anticipating technology innovation and adoption, she has served as a trusted advisor to many industry leaders over the years. Judith has helped these companies make the transition to a new
business model focused on helping businesses to anticipate and solve customer needs. She was the founder of CycleBridge, a life sciences software consulting firm and Hurwitz Group, a research and consulting firm. She has worked
in various corporations including Apollo Computer, and John Hancock. In 2011 she authored Smart or Lucky? How Technology Leaders Turn Chance into Success. (Jossey Bass, 2011). She has co-authored numerous Dummies Books published
by Wiley including Big Data for Dummies and Hybrid Cloud for Dummies.
Previously, she was the founder of CycleBridge, a life sciences software consulting firm and Hurwitz Group, a research and consulting firm. She has worked
in various corporations including Apollo Computer, and John Hancock. In 2011 she authored Smart or Lucky? How Technology Leaders Turn Chance into Success. (Jossey Bass, 2011). She has co-authored numerous Dummies Books published
by Wiley including Big Data for Dummies and Hybrid Cloud for Dummies.
|Mary Margaret Jacobs||The Johns Hopkins Hospital||AI in Healthcare|
Director, Capacity Management
Mary Margaret Jacobs is the Director of Capacity
Management at The Johns Hopkins Hospital. Her areas of responsibility include Admitting and Registration, Operating Room and Procedure Registration, Bed Management, and the Patient TV and Phone Program. In addition, she has recently
accepted a new role leading efforts to manage hospital capacity for Johns Hopkins. In this role, Mrs. Jacobs leads institutional efforts at process improvement and has operationalized a one of a kind, hospital Capacity Optimization
Command Center. Through her career at The Johns Hopkins Hospital, Mrs. Jacobs has been a nursing and hospital leader. She has managed nursing units for the Department of Medicine and developed programs for improving the patient
experience. Mrs. Jacobs is a founding organizer of the JHH Patient Family Advisory Council, which has grown to more than seven councils with over one hundred patient advisors. She developed and implemented a centralized bed management
program and is a business owner for the Epic Access System. She is a graduate of the Trenton State College School of Nursing and completed her Graduate Degree at the University of Maryland, School of Nursing in Gerontology and
Nursing Administration. She also has received a certificate in the Business of Nursing from the Johns Hopkins School of Nursing.
|Seth Jamison||Pure Storage||Going from Big Data to AI|
Principal Solutions Architect, FlashBlade
Seth Jamison is a Principal Solutions Architect for FlashBlade at Pure Storage, where he is a senior technical advisor to engineering, product management, sales, marketing and presales leadership in the field. Since 2013, Seth
has held various individual and presales leadership roles within Pure and has been a trusted advisor to his customers since moving into the data storage industry in 2000. Prior to Pure Storage, Seth spent eight years with Dell
Inc., most recently as a Field CTO / Enterprise Technologist in the Office of the CTO.
|Kamal Jethwani, MD||Harvard Medical School||Seminar: AI in Personalized Medicine and Digital Health|
Senior Director, Connected Health Innovation, Partners HealthCare (PHS), Assistant Professor
As the Senior Director, Dr. Kamal Jethwani leads the research and program evaluation initiatives at Partners Connected Health Innovation. He has designed and implemented multiple clinical trials; led predictive modeling efforts
using behavioral parameters; and worked extensively with sensor technology, wearables, mobile applications, texting, and social media to deliver patient care. Kamal is currently exploring newer health delivery models, including
employer-based health programs and online social-network-based programs. He focuses on technology-based models of health delivery and leverages behavior-change principles for preventive and supportive care. He tries, always, to
personalize care and understand the behavioral motivations that dictate people’s health choices.
|Deeksha Joshi||Liberty Mutual Insurance||Implementing Enterprise AI|
Managing Director, Corporate Strategy and Research
Deeksha is a Managing Director in Corporate Strategy and Research at Liberty Mutual Insurance. Being an Innovation Strategist (Transformational technologies), Deeksha spends her time researching disruptive trends, technologies
and trying to understand the future of risk. She is a speaker, author and has over 15 years of experience working with multiple companies around the technology and innovation space. At Liberty, She helps thinks though and solve
various strategic and operational challenges as Insurance industry is experiencing new trends and opportunities. Previously, she led property Innovation team in US Retail Markets. She authored 2 books on data & innovation:
Data Driven Innovation & TheBigAnalytics. Before joining Liberty, she was an Executive at Strategy and Transformation group within Accenture’s management consulting organization and led large transformation projects.
She has also created and ran her own IT consulting firm in India. When not wearing the futurist hat, Deeksha loves to hike, and learn what nature has to teach. She has received an MBA from Darden School of Business, Virginia and
her Bachelors in Engineering from NSIT, Delhi. She also shares passion for sharing her thoughts via blog and supporting local Boston startups and supporting girls in STEAM initiatives.
|Natalija Jovanovic, PhD||Sanofi||AI in Pharma|
Head Digital Catalyst
Natalija Jovanovic is a Head Digital Catalyst in the Global Digital and Analytics team, supporting implementation of Sanofi's digital strategies. She has extensive experience in delivering digital solutions at AIG, the global
insurer, and as VP of Innovation at Brown Brothers Harriman, a global commercial bank. Previously, Natalija was at McKinsey, the strategy consulting firm, and holds a PhD in electrical engineering from MIT.
|Krishna Kallakuri||diwo||Cognitive Computing|
Krishna’s visionary leadership and delivery of transformational BI and Analytics initiatives to leading Fortune 500's has landed the practice he has founded on the Midwest’s Fastest-Growing list. As CEO of DatafactZ,
His passion for Advanced Analytics, Cognitive Technologies, and Artificial Intelligence have led to pioneering work. Krishna recently launched diwo, a unique cognitive decision-making platform developed by Loven Systems that reveals
hidden business opportunities in real-time and empowers business users to act on them.
|Jan Kanty Milczek||deepsense.ai||Seminar: Enterprise Machine Learning & Deep Learning|
Senior Data Scientist
Jan is one of the founding
members of the data science team providing machine learning services for international customers. He has led projects focusing on cybersecurity. The team has placed in numerous competitions, including a a 1st place finish in the
Kaggle Right Whale Recognition challenge. He has a strong computer science background as an award winner in informatics and a teacher of courses on algorithms and data structures. In his data science work, he places particular
emphasis on validation routines.
|Dan Kara||WTWH Media||State of the Technology: Making Robots Intelligent, Cognitive and Aware|
Vice President, Robotics and Intelligent Systems
Dan Kara is Vice President, Robotics at WTWH Media where he is charted with driving the company’s robotics initiatives including the Robot Report online portal and The Robotics Summit Conference and Exposition. Prior to
joining WTWH, he was Practice Director, Robotics at ABI Research and Chief Research Officer for Myria RAS, both research and advisory services firms focused on automation, robotics and intelligent systems. Dan was also President
of Robotics Trends, an integrated media and research firm serving the personal, service and mobile robotics markets. He was the developer and past chairman of the RoboBusiness Conference and Exposition series, the RoboDevelopment
Conference and Exposition series, the RoboNexus Conference and Exposition series, and the CES Robotics TechZone. He holds a MS in Computer Science from Boston University.
|Matt Karlyn||Foley & Lardner LLP||Enterprise AI Strategies Theater|
Co-Chair Technology Industry Team
|Aditya Kaul||Tractica||Emerging Technologies and the Future of AI|
|Josh Kellar||Boston Consulting Group (BCG)||AI in Healthcare|
Partner and Managing Director
Josh Kellar is a Partner
in the Chicago office of the Boston Consulting Group. He has worked across all health care sectors with a strong focus on genomics, advanced analytics and AI, individualized medicine and new payment models in Healthcare, particularly
for providers. He is a core member of BCG's health care practice and the leader of BCG’s Global Scientist Network, with over 500 MDs and PhD consultants.
Prior to joining BCG, Josh earned a PhD from Northwestern University
where his research focused on the use of carbon nanomaterials for use in targeted drug delivery and genomics, including a postdoctoral fellowship in oncology applications. He also holds an MA in poetry from Boston University and
a BS from Georgetown University where he majored in physics and English.
|Chida Khatua||EquBot||Enterprise AI Strategies Theater|
Chida Khatua, Founder & CEO of EquBot. EquBot is democratizing access to sophisticated Investment technology. Equbot is leading in using Artificial Intelligence in finding investment opportunities and quantifying the influencers
of opportunities. Equbot innovative approach redefines how big data and AI can be used to disrupt finance industry. EquBot launched first AI powered ETF in NYSE and gathered more than $150M in 3months. EquBot is bringing customizable
Portfolio at scale for millions of investors. Chida holds several patents to his credit. Chida started his career in CPU design at Intel and was director of engineering at Intel. Chida have also co-founded Bumper Glass an innovative
Ad tech company. Chida holds Master from Indian Institute of Science and Stanford and MBA from Haas school of Business.
|Keith Kirkpatrick||Tractica||Enterprise AI Strategies Theater|
Keith Kirkpatrick is a principal analyst contributing to Tractica’s User Interface Technologies practice, with a focus on emerging interface technologies for automotive, consumer, enterprise, and industrial markets. Kirkpatrick,
who is based in New York, has more than 20 years of experience in a variety of research, marketing, and consulting-based fields. Kirkpatrick began his career as a financial and technology journalist, and has written for a wide
variety of national and trade publications. He has authored a wide range of primary market forecast studies covering a range of technology and communications topics for private clients, market research companies, and his own firm,
4K Research & Consulting, LLC. He is a member of the Association of Independent Information Professionals (AIIP), and holds a BA in magazine journalism and sociology from Syracuse University.
|David Kiron, PhD||MIT Sloan Management Review||Executive Summit|
is the executive editor of MIT Sloan Management Review where he directs The Big Ideas Initiative, a content platform examining macro-trends that are transforming the practice of management. Dr. Kiron has coedited two books on economics;
coauthored 20+ journal articles and research reports on analytics, sustainability, and digital technology; and written 50+ Harvard Business School case studies. Dr. Kiron currently serves as an expert panelist on the Fraunhofer
Institute’s Future of Operating Procedures project. He has a Ph.D. in philosophy from the University of Rochester and a B.A. from Oberlin College.
|Kashyap Kompella||RPA2ai Research||Going from Big Data to AI|
Kashyap Kompella, CFA is CEO and chief analyst of rpa2ai Research,
a global industry analyst firm for automation and Artificial Intelligence. Kashyap has 20 years of experience as an industry analyst, technologist and management consultant. rpa2ai helps customers with enterprise AI/Automation
strategy and roadmap, technology selection and M&A due diligence on AI technologies.
Kashyap is widely recognized as a thought leader on AI and emerging technologies and has been quoted by the BBC, Quartz, Economist, Mint,
Guardian, Forbes, Nikkei Asian Review, eMarketer, CMSWire, KMWorld, EContent, SearchCIO etc., and has presented at several global conferences. Kashyap has been a judge for EContent 100, a list of the Top 100 digital companies.
Kashyap is the author of the forthcoming “Future Tense: Surviving and Thriving in the age of AI”.
|Lalitha Kompella||Genpact||Enterprise AI Strategies Theater|
CTO, Digital, Banking and Financial Services
Kashyap is widely recognized as a thought leader on AI and emerging technologies and has been quoted by the BBC, Quartz, Economist, Mint, Guardian, Forbes, Nikkei Asian Review, eMarketer, CMSWire, KMWorld, EContent, SearchCIO
etc., and has presented at several global conferences. Kashyap has been a judge for EContent 100, a list of the Top 100 digital companies. Kashyap is the author of the forthcoming “Future Tense: Surviving and Thriving in
the age of AI”. Lalitha has twenty-seven years of experience across technology architecture, application services, and automation of business processes. She currently leads Genpact’s Intelligent Automation Consulting
and serves as the Digital CTO for Global Banking and Capital Markets. Lalitha is instrumental in setting up Automation Centers of Excellence (COEs) for global clients across industries, identifying digital interventions for process
transformation, and implementing automation solutions in robotic process automation (RPA) and artificial intelligence (AI). Previously, Lalitha was the Head of Application Services and North America delivery leader for HCL banking,
insurance, and capital markets clients. Prior to joining Genpact more than two years ago, Lalitha was Global Leader for Wipro’s Transformation programs and Chief Architect for Wipro’s Emerging Technology initiatives.
She has a Masters degree in Computer Science and Applications and a Bachelor’s degree in Electronics. She is based in New York City.
|Benn Konsynski||Emory University||Workshop: Deploying and Scaling Enterprise AI Systems|
Prof of Information Systems & Operations Mgmt, Goizueta Business School
|Srinivas Krovvidy||Fannie Mae||Enterprise AI Strategies Theater|
Director, Advanced Analytics Enablement
Dr. Srinivas Krovvidy (Srini) is Director and Head of Advanced Analytics Enablement group at Fannie Mae overseeing analytic transformation journeys of various teams and development of data science applications. His experience
includes leading enterprise shared services such as business rules & BPM. He received multiple awards from AAAI (Association for Advancement of Artificial Intelligence) for development of innovative applications. Srini received
his PhD in machine learning and published 20+ articles in international journals, magazines and conference proceedings in the areas of machine learning and AI. He is a senior member of ACM (Association for Computing Machinery)
and member of AAAI.
|Kurt Kuckein||DDN Storage||AI in Pharma|
Senior Director, Marketing
Kurt Kuckein is Sr. Director of Marketing for DDN, based in Silicon Valley with responsibilities of Product and Corporate Marketing.
Kurt joined DDN in 2015. Prior to joining DDN, he worked at EMC in the Data Protection Division, Silicon Graphics in the Storage Solutions Group, and CGNET’s hosted management services.
|Vishal Kumar||AnalyticsWeek||Implementing Enterprise AI|
|Tolga Kurtoglu, PhD||PARC||Plenary Session|
Dr. Tolga Kurtoglu is CEO of PARC, a Xerox
company, which is in "the business of breakthroughs.” Dr. Kurtoglu specializes in leading cross-functional teams to apply science and technology to develop creative solutions to real-world problems. Dr. Kurtoglu was named
Chief Executive Officer of PARC in January 2017, after serving as PARC Vice President, Director of System Sciences Lab, where he oversaw development of software technologies used for the design, verification, manufacturing, and
operations of complex systems.
Dr. Kurtoglu’s other leadership roles at PARC have included Research Scientist/Area Manager in computational sciences, AI and automation. Prior to joining PARC, Dr. Kurtoglu was a Research
Scientist for NASA Ames Research Center and a Systems Lead Engineer for Dell.
Dr. Kurtoglu’s own research was focused on computation and artificial intelligence applied to design and manufacturing of complex systems,
and application of preventive and predictive analytics techniques to engineered systems. He received his Ph.D. from the University of Texas at Austin and M.S. from Carnegie Mellon University, both in Mechanical Engineering. He
holds a bachelor’s degree in the same field from Orta Dogu Technical University (ODTU).
Practicing open innovation since being incorporated in 2002, PARC provides custom R&D services, technology, specialized expertise,
best practices, and intellectual property to Xerox’s business groups, Fortune 500 and Global 1000 companies, startups, and government.
|Jason Kurtz||Harte Hanks||Workshop: Deploying and Scaling Enterprise AI Systems|
Executive Director, Analytics
Jason has more than 20 years of experience in marketing consulting, digital media and CRM. Since 2005 Jason has led the development and implementation of database marketing capabilities, analytical solutions and strategic programs
in a wide variety of industries for leading companies including Dell Technologies, DirecTV, T-Mobile, and Limited Brands.
|Dale Kutnick||Gartner||Plenary Session|
Senior Vice President, Emeritus, and Distinguished Analyst
Dale Kutnick is a Senior VP, Emeritus, and Distinguished Analyst at Gartner. He works with CIOs and senior business leaders to help them better manage and exploit technology innovation to drive business outcomes. From 2007-13,
he was global leader of Gartner's Executive Programs, which more than doubled its contract value and dramatically enhanced customer engagement. Kutnick is a regular speaker at Gartner events, and works directly with numerous CIOs
and senior executives on IT-enabled business strategies.
Kutnick “re-joined” Gartner in 2005 as part of the META Group (METG went public in ‘95, and grew to $100B by 2000) acquisition; he was its co-founder
and Chairman of the Board and also served as President, CEO and Research Director from its inception in 1989 until 2003. In addition to his operational duties, Kutnick led the development and management of content quality. Before
co-founding META Group, Kutnick was EVP of Research with Gartner and an Executive Vice President at Gartner Securities. He was also Exec Director of Research at Yankee Group, and a principal at Battery Ventures. He was on the Board
of Directors of First Albany Corp. and Broadpoint Securities from 2005-08. He currently serves on the board of i.c.Stars (Chicago), on the board of Riverkeeper (New York), and on the IT Advisory Boards at Danbury Hospital and World
Kutnick is a graduate of Yale University. He is also secretary of the Dale and Laura Kutnick Foundation, which contributes funds to nonprofit education, medical, environmental and socially responsible causes.
|Adam Landman, MD||Brigham and Women’s Hospital||AI in Healthcare|
Vice President and CIO
Adam Landman, MD, MS,
MIS, MHS is Vice President and Chief Information Officer at Brigham Health (BH), Assistant Professor of Emergency Medicine at Harvard Medical School, and an attending emergency physician at BWH. He is an expert in information systems
development and implementation. He led a three-year, $7 million custom software development project to move BWH Emergency Department clinicians from paper-based to electronic documentation. Over the past three years, he helped
oversee the implementation of Epic and several critical laboratory information systems. Dr. Landman has also designed and developed mobile apps to securely capture and store clinical images and to improve electronic medication
administration and reconciliation. He also created the BWH Digital Health Innovation Group to spur hospital use of digital technology as well as facilitate appropriate use of digital tools by clinicians, innovators, and researchers.
As CIO, he is currently responsible for the stabilization and optimization of the EHR, all other hospital information systems, and digital health innovation.
|Jessica Langdorf||Nuance Communications, Inc.||Emerging Technologies and the Future of AI|
Director, Digital Engagement Lab
As Director, Digital Engagement Lab at Nuance, Jessica Langdorf brings 20+ years of operational planning and process improvement experience with 10+ years in the digital optimization area for telecom, financial services, and
retail industries. Jessica is responsible for strategic solution design and online engagement best practice definition, execution, and optimization.
|Danny Lange, PhD||Unity Technologies||Plenary Session|
Vice President of AI and Machine Learning
Danny Lange is VP of AI and Machine Learning at Unity Technologies. He joins from Uber, where he was Head of Machine Learning. At Uber, Danny led the efforts to build the world’s most versatile Machine Learning platform to
support Uber’s hyper growth. As VP of AI and Machine Learning, Danny leads Unity’s efforts around AI (Artificial Intelligence) and Machine Learning.
Previously, Danny was General Manager of Amazon Machine Learning
-- an AWS product that offers Machine Learning as a Cloud Service. Before that, he was Principal Development Manager at Microsoft where he led a product team focused on large-scale Machine Learning for Big Data. Danny spent eight
years on Speech Recognition Systems, first as CTO of General Magic, Inc., then through his work on General Motors OnStar Virtual Advisor, one of the largest deployments of an intelligent personal assistant until Siri. Danny started
his career as a Computer Scientist at IBM Research.
Danny holds MS and Ph.D. degrees in Computer Science from the Technical University of Denmark. He is a member of ACM and IEEE Computer Society and has several patents to
|David Ledbetter||Children’s Hospital Los Angeles|
Lead Data Scientist
Mr. David Ledbetter has
an extensive and deep understanding of decision theory. He has experience implementing various decision engines, including convolutional neural networks, random forests, extra trees, and linear discrimination analysis. His particular
area of focus is in performance estimation, where he has been able to accurately predict performance on new data in nonstationary, real-world scenarios, including detecting circulating tumor cells in blood, automatic target recognition
utilizing CNNs from satellite imagery, make/model car classification for the Los Angeles Police Department, and acoustic whale call detection from underwater sonobuoys. Recently, he has been developing a Recurrent Neural Network
to generate acuity scores and personalized treatment recommendations to optimize patient outcomes using electronic medical records from 15 years of data collected from the Children’s Hospital Los Angeles Pediatric Intensive
|Michelle Li||MIT||Strategic Business Functions and AI|
Director, MIT Master of Business Analytics Program
Michelle Li is the Director of the Master of Business Analytics (MBAn) program, a joint collaboration between the MIT Sloan School of Management and the Operations Research Center. Alongside MIT leadership and faculty, she helped
to design and launch the program in 2015. Ms. Li currently oversees the MBAn program’s curriculum, admissions, corporate partnerships and overall strategic direction in order deliver the number one data science and analytics
degree in the world. Prior to her work at MIT, Ms. Li served as the Director of the Global Technology Group at UBS Investment Bank. Ms. Li is a CFA charterholder and graduated from Cornell University with a Master of Engineering
and Bachelor of Science in Computer Science and Operations Research.
|Ser-Nam Lim, PhD||Facebook Applied Machine Learning||Implementing Enterprise AI|
Research Scientist Manager
Dr. Ser Nam Lim is currently
a research manager at Facebook. He has led and conducted research in computer vision for over a decade. His research interests in computer vision currently are focus on adversarial learning, transfer learning and intent recognition.
He is an evangelist of computer vision that generalizes while also being passionate about computer vision applications that change the world. His current work at Facebook is a direct testimony to this where he is leading a team
of computer vision scientists and engineers to develop the next generation of algorithms that are capable of protecting the safety of Facebook platform by automatically understanding images and videos that are posted on Facebook
in large quantities.
|Shi-Wan Lin||Thingswise||AI & Real-time IoT|
CEO & Co-Founder
Dr. Lin brings 20+ years of broad technology and business experience from Intel, Sarvega, Lucent Technologies and Motorola to the company. Prior to founding the company, he was a chief technologist in the IoT Strategy and Technology
Office at Intel. Dr. Lin co-chairs various technical groups for the Industrial Internet Consortium (IIC), the National Institute for Standards and Technology Cyber-Physical Systems Public Working Group, the Joint Task Group between
Platform Industrie 4.0 and the Industrial Internet Consortium.
|Craig Lipset||Pfizer||AI in Pharma|
Head of Clinical Innovation
Craig Lipset is Head
of Clinical Innovation within Global Product Development at Pfizer. Craig’s team is impacting clinical research through digital tools, innovative research approaches and game-changing collaborations. Craig previously served
as Venture Partner in Pfizer Venture Investments (Pfizer’s VC arm), where he focused on diversifying the company’s $50M annual budget for private investments in the areas of diagnostics and health technology. Craig
was also Senior Director in Molecular Medicine, where he spearheaded initiatives driving innovation in clinical research and personalized medicine by drawing upon tools from health information technology, telemedicine, and eHealth.
Craig brings over 15 years of leadership and innovation in the field of drug development. He previously served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on
the founding management team for Perceptive Informatics (now part of PAREXEL International). Craig has been listed among the PharmaVOICE most inspiring people in the life sciences, Pharmaceutical Executive’s Emerging Leaders,
CenterWatch Top Innovators, and AlleyWatch Who's Who in eHealth. He serves on the Editorial Board for Therapeutic Innovation & Regulatory Science. Outside of Pfizer, Craig serves on the Board of Directors for the People-Centered
Research Foundation, Foundation for Sarcoidosis Research and MedStar Health Research Institute, and is a Mentor at health tech accelerator Blueprint Health.
|Rivka Little||Global Payment Strategies, IDC||Executive Summit|
Rivka Gewirtz Little is Research Director for IDC Financial Insights responsible for the global payments practice. Ms. Little’s core research coverage includes the transformation of payment networks and technology, including
the global move to real-time payments, as well as the connected banking ecosystem. Before joining IDC, Ms. Little lead the product marketing organization at financial crime and compliance technology provider NICE Actimize. Ms.
Little worked with the Actimize product team to expand enterprise AML and fraud prevention systems with AI and advanced automation.
|Andrew W. Lo||MIT Sloan School of Management ||Plenary Session|
The Charles E. and Susan T. Harris Professor, Professor of Finance, Director of the Laboratory for Financial Engineering
Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management and director of the MIT Laboratory for Financial Engineering. Andrew is faculty co-director of the newly launched Fintech@CSAIL
initiative. He received his Ph.D. in economics from Harvard University in 1984. Before joining MIT’s finance faculty in 1988, he taught at the University of Pennsylvania’s Wharton School from 1984 to 1988. He has published
numerous articles in finance and economics journals (see http://alo.mit.edu/), and has authored several books of which the latest is Adaptive Markets: Financial Evolution at the Speed of Thought. His research interests include
algorithmic trading, risk management, evolutionary models of financial markets and human behavior, machine learning models of consumer credit risk, and applications of secure multi-party computation to financial regulation and
cybersecurity risk measurement. His awards include Alfred P. Sloan Foundation and Guggenheim Fellowships, the Paul A. Samuelson Award, inclusion in Time Magazine's "100 Most Influential People in the World" in 2012, the 2017 Harry
Markowitz Award, the 2017 Global Association of Risk Professionals Risk Manager of the Year, the 2018 CME Group and BarclayHedge Pinnacle Achievement Award, and awards for teaching excellence from both Wharton and MIT.
|Scott Lundstrom||IDC||Executive Summit|
Group Vice President & General Manager
Scott Lundstrom is a long time industry analyst focused on the transformative and disruptive nature of technology. Mr. Lundstrom has been focused on IT driven business innovation and change in a variety of industries and settings.
Mr. Lundstrom is an expert on the emerging third platform, and speaks regularly on the future of cloud, analytics, mobility, and social media to digitally transform and radically alter the process and services offered to customers
in the marketplace.
|Jai Malhotra||Applied Intelligence||AI Technology Solutions Theater|
Bio coming soon.
|Marc Mancher||Deloitte Consulting LLP||Enterprise AI Strategies Theater|
US Government and Public Services Robotics & Intelligent Automation Lead
Marc Mancher is a Principal in Deloitte Consulting and serves as the Global Public Sector Robotics Leader. Prior to his current role, he led Deloitte’s commercial Insourcing and Outsourcing Advisory business lines. Over
the past 25 years, Marc has advised, built, run, sourced, and/or operated IT, HR and Finance shared services and call centers internationally for household names such as Google, IBM, T-Mobile, USAA, Anthem, and various government
entities. In addition to Marc’s significant professional operations experience, he recently completed 30 years of Active and Reserve service in the US Navy with prior duty on the ground in Afghanistan. In 2017, Marc was awarded
the Innovator of the Year award from the Washington Business Journal, and can be frequently discovered in media channels, such as The Financial Times, Fortune Magazine, WSJ, Government Computer News, FedScoop, Inside Supplier Management,
and a variety of other publications.
|Mary McKenna||Interactions||AI Bot Workshop|
Director, Product Management
Bio coming soon.
|Sara Mattingly Jordan, PhD||Virginia Tech University||Cognitive Computing|
IEEE Global Initiative for Ethical AI
|John Mattison, MD||Kaiser Permanente||AI in Healthcare|
John has always been drawn to analysis
of complex interactive systems. His interest in evolutionary and marine biology produced a lens of teleology that informs how he approaches complex system issues. That lens helps sequence, converge and map disparate technologies
into solutions that address fundamental human needs and aspirations. As a physician he practiced in a wide variety of clinical specialties and venues, from hospital intensivist to primary care and preventive medicine, and he was
a founding physician for LifeFlight Helicopter Trauma system and the Hyperbaric medicine programs at UCSD. While continuing his practice he was appointed Chief Health Information Officer for the largest Kaiser-Permanente region,
SCAL. He assembled one of the best clinical informatics and integrated clinical operations teams completed KP’s digital transformation project a year ahead of schedule and $267M under budget. One of the critical priorities
now is to reduce the burden of EHRs and the impact on physician burnout, which is where machine learning can play a powerful role. He has immersed himself in numerous technical and socio-behavioral disciplines to accelerate the
usability and use of digital data resources for the advancement of health, wellness and happiness. He was founder of the XML standard for health record exchange, known as the CDA, CCD, and cCCD, served as a member of the SNOMED
International board, and has contributed to standardizing data ontologies across many fields, including phenomics (EHR/PHR data), genomics, proteomics, and neurosciences (as a member of the Ontario Brain Institute Advisory Board).
He is currently experimenting with various use cases where distributed ledgers can be applied to health information to support how individuals can more safely and productively participate in both their own health care and in the
advancement of medical science. He is an advisory board member for the NIH funded “Ethics and Policy for Creating a Medical Information Commons” for the Precision Medicine Initiative. He teaches various aspects of health
technology, policy, and leadership at many universities, including UCSD, Stanford, UCLA, UCSF, and Singularity University, where he speaks and conducts workshops at the Exponential Medicine course every year. He was led several
workgroups for the Global Alliance for Genomics and Health (GA4GH), and he recently led a roundtable at the National Academies of Science, Engineering and Medicine on the future roles that blockchain and homomorphic encryption
can play in genomics research and practice. He has published on a wide variety of topics, including co-editing the 2018 textbook on Health Information Technology, and has received various awards for contributions across many intersections
of healthcare, health IT, informatics and policy. His professional passion is the convergence, operationalization and scaling of multiple exponential technologies and he is actively engaged in a wide range of projects involving
ontologies, big data and predictive analytics, NLP and machine learning, data visualization, IOT, blockchain, genomics, microbiomics, privacy, health policy, mobile health apps and wearable sensors, and virtual care/telemedicine
and cybersecurity, and he serves on the California State Task force on Cybersecurity. He is in the early stages of designing and planning a drone infrastructure for rapid delivery of clinical services through a wide variety of
use cases. He serves on the boards of several philanthropic organizations focused on improving early childhood experiences and advancing restorative narrative in journalism. John has mentored scores of startups in health IT internationally
on a pro bono basis. One of his current passions in anticipating the unintended consequences of machine learning, and the risks associated with advanced generalized intelligence, to stimulate a broader public discussion of how
to mitigate those risks and minimize the inherent biases towards social inequity and isolation. His personal passions include underwater photography, surfing, and spending time with family, friends, and his golden retrievers.
|Mainak Mazumdar||Nielsen||Seminar: Enterprise Machine Learning & Deep Learning|
Chief Researcher Officer
Mainak Mazumdar is a Data Science executive with 20+ years of experience in Data and Technology businesses. As a C-level executive in both tech start-up and publicly trade firms, Mainak has demonstrated leadership in building
world-class teams and driving innovation for growth. An expert in digital transformation, Mainak is leading business transformation through Machine Learning and AI.
As the Chief Research Officer with the Nielsen Company, Mainak
leads a team of 1000+ Data Scientists focused on driving innovation and re-imagining the Nielsen measurement business through Machine Learning and Artificial Intelligence. Mainak is a member of CEO’s Nielsen Global Leadership
team. Before this second tenure with Nielsen- when he had led innovation for the firm, Mainak developed Data Science team and products for Simulmedia, a Data Management Platform for Programmatic TV. Prior to Simulmedia, as the
Chief Strategy Officer of GfK, Mainak led digital transformation for the measurement company. Earlier in his career, Mainak spend several years with Ad Tech start-ups, including DoubleClick Inc. (acquired by Google), where he led
research and analytics for adserver products.
Mainak holds an undergraduate international economics degree from the American College, witzerland and has an M.A in Demography from Brown University. He lives in Brooklyn with
his wife, son and a dog.
|Jelani Akil McLean, EdD, MPA||BlueCross BlueShield Association||AI in Healthcare|
Managing Director, Clinical Platforms
Jelani Akil McLean is the Managing Director, Clinical Platforms for the Office of Clinical Affairs (OCA) at BlueCross BlueShield Association (BCBSA). McLean is responsible for the development, implementation, and management of
all platform-based businesses in OCA, which includes the Evidence Positioning System™ (EPS), Evidence Street™, and the Fast Network StarSuite™. Prior to his current role, McLean was responsible for leading the
Network Economics practices within the division, where he focused on health and healthcare markets that benefit from and/or affected by the network effect. In that role, McLean led the development of business applications such
as Evidence Street™ and Community Health Management Hub® (CHM Hub®). Specifically with CHM Hub®, McLean implemented a framework for Social Determinants of Health and HubMatch™. McLean has also served as
an expert advisor to the National Quality Forum (NQF) for the Episode Grouper Criteria project in 2014. Prior to joining BCBSA, McLean was a Senior Analytic Consultant at Blue Health Intelligence (BHI), where he was responsible
for leading national health economic and outcome measures programs, including serving as the Analytic Project Lead for BCBSA’s Blue Distinction Centers™ Program for Specialty Care. McLean also led and implemented BHI’s
Quality Assurance initiatives and operations, including creation and integration of repeatable quality control reports and analysis for enterprise-wide improved analytics. McLean received a bachelor’s degree in Psychology
from Florida State University, later obtaining a Master’s of Public Administration and Doctorate, with research in Applied Mathematics for Economic & Decision Sciences.
|Dipa Talati Mehta||Sandbox Industries||AI in Healthcare|
Dipa is a Managing Director at Sandbox Industries, a
Chicago-based venture capital firm focused on implementing innovation by connecting established corporations with innovative startups and entrepreneurs. Dipa focuses on investing in healthcare innovation through the BlueCross BlueShield
Venture Funds, a collaborative investment platform with over $575 million in capital and 30 Blue Plans participating. She currently serves on the board of directors of Oncology Analytics and a board observer at Contessa Health
and BehaveCare. Prior to Sandbox, Dipa was at Amgen Ventures, the corporate venture fund of Amgen. Previously, she held positions at UBS in the Global Healthcare Investment Banking group and the Healthcare Fund at Paul Capital
Partners, which invested in late-stage pharmaceutical and biotechnology companies. Dipa holds a BS from the New York University Stern School of Business and an MBA from the University of Chicago Booth School of Business where she
received the Chicago Booth Leadership Award of Distinction. Dipa is also a Kauffman Fellow. She lives in Chicago, IL with her husband and twin baby boys.
|William Meisel, PhD||TMA Associates||WORKSHOP - Building Intelligent Assistants & Chatbots|
SEMINAR - Building AI-powered Natural Language Solutions
Chief Innovation Officer
William Meisel, Ph.D., president, TMA Associates, is publisher and editor of LUI News (formerly Speech Strategy News), a paid-subscription monthly newsletter launched in 1993, which covers the commercial applications of the Language
User Interface. Dr. Meisel has authored the most comprehensive digital assistant product guide in the market today which covers 270+ intelligent assistant/Bot products and 125+ implementations – Digital Assistants and Bots:
A Vendor Guide. He chairs the Conversational Interaction Conference for AVIOS, and he produces a ½ day workshop at our AI World event entitled “Building an Application-Specific Intelligent Assistant”. He is author
of the 2013 book The Software Society, and a consultant on market and product opportunities created by the maturing of speech and natural language technology. His experience in speech technology includes founding and running a
speech recognition company and authoring a technical book on machine learning. Dr. Meisel previously founded a venture-capital-backed speech recognition company, Speech Systems Inc., and ran it for ten years. Dr. Meisel’s
experience combines a strong academic, technical, and business background. With a B.S. degree in Engineering from Caltech and a Ph.D. in Electrical Engineering from the University of Southern California/ Je was a professor of Electrical
Engineering and Computer Science at USC, where he published over 70 papers and several books. He has been issued eleven patents in various areas of technology. After working in university research, Dr. Meisel launched and managed
the Computer Science Division of an aerospace company, applying pattern recognition technology to a number of application areas, including target detection and intelligence data analysis.
|Laurie Menoud||BASF Venture Capital||Going from Big Data to AI|
At BASF Venture Capital North America, Laurie Menoud
focuses on equity investments in early- and growth-stage companies with a focus on digital technologies. Previously, she led the creation of a dozen of new ventures at SRI International, with an emphasis on human augmentation and
automation. She is passionate about entrepreneurship, bringing her experience working at startups and corporate innovation groups to successfully commercialize innovation.
|Raj Minhas, PhD||PARC||Emerging Technologies and the Future of AI|
VP and Director of the Interactions and Analytics Lab (IAL)
Raj Minhas leads the AI research lab at PARC that focuses on people, their behaviors, and interactions with machines. The lab conducts research on all aspects of human-machine interaction including computer vision, conversation
agents, explainable AI, and human-machine teaming.
Raj joined PARC in September 2013 and prior to that, he was the Director of Xerox Research Center India where he led its growth, development, and outreach for two years. He
also held a variety of leadership roles at Xerox Research Center Webster including manager of analytics and large-scale computing research. Raj earned his M.S. and Ph.D. in Electrical and Computer Engineering from University of
|Norbert Monfort||Assurant||Plenary Session|
Vice President, IT Transformation & Innovation
Norbert Monfort serves as Vice President of IT Transformation and Innovation at Assurant. He also teaches IT-related topics as an Adjunct Professor at Florida International University. Monfort has worked in Information Technology
at Fortune 500 companies for over 30 years in management and as a senior engineer. He has authored three science fiction books with "The Scalian Legacy" being the latest, best-selling and best reviewed of his novels. Monfort earned
his M.S. in Information Technology and his B.S. in Computer Science from Florida International University.
|Kwame Monthrope||Accenture||Workshop: Deploying and Scaling Enterprise AI Systems|
Global CRM Executive
|Henry Morris||Henry Morris Analytics||Going from Big Data to AI|
Henry Morris founded analytics research at IDC and writes on analytic
applications and the need for ethical controls and governance of intelligent system. His career has ranged from teaching analytic philosophy to writing and speaking on analytics software. He is currently researching and writing
a book on augmented intelligence.
|James D. Murray||CVS Health||AI in Healthcare|
VP, Clinical Informatics and Interoperability
James Murray, MS, CPHIMS is Vice President, Information Technology for MinuteClinic at CVS/Caremark. He is responsible for the all systems and solutions to support over 800 walk in medical clinics.
Mr. Murray works to support
a medical practice of over 2500 providers by enabling the efficient use of technology in the clinical setting. MinuteClinic maintains a strong focus on collaboration with medical systems in the communities we serve. The integration
of medical records with their affiliate institutions across the country helps to improve continuity of care and enable communication around all aspects of a patient’s care.
Mr. Murray has over 20 years’ experience
in Healthcare Information Technology at BWH, MGH and Partners Health. Mr. Murray is a member of the Board of Directors for eHealth Initiative in Washington, D.C. He holds a bachelor’s degree in economics from the University
of Nebraska and a Master of Science in Medical Informatics from Northwestern University.
|Vivian K. Mushahwar, PhD||University of Alberta||Plenary Session|
|Eric Neumann||Aidaka||AI in Pharma|
CEO & Founder
Dr Eric Neumann is CEO and founder
of AIDAKA, a deep learning technologies and services company started last June of 2017. AIDAKA leverages the solution finding power of deep learning systems together with existing prior biomedical knowledge, to solve many pharmaceutical
and healthcare challenges.
Dr Neumann is a recognized world expert in semantic information and data modeling for the life sciences, and has worked on many information standards initiatives for the pharmaceutical and life sciences.
Dr Neumann was vice president of Knowledge Informatics at Foundation Medicine, responsible for organizing FMI’s knowledge assets and supporting knowledge discovery initiatives.
Dr Neumann has co-founded several other
companies, including Selventa, Clinical Semantics, and Pangenx, and Beyond Genomics, a systems biology company. Dr Neumann was also the Global Head of Knowledge Management for Sanofi-Aventis.
Dr Neumann is a graduate from
MIT and holds a PhD in neurobiology, developmental genetics, and pharmacology from Case Western Reserve University. His post-doctorate research applied neural networks to genomic and phenotypic characterization of Drosophila mutations
in Dr. Jeffrey Hall’s lab, the 2017 recipient of the Nobel Prize in Medicine.
|Barry Olafson, PhD||Protabit LLC ||AI in Pharma|
Dr. Barry Olafson, PhD, has spent his career developing computational
approaches to the study of proteins. He is one of the original developers of the Charmm molecular dynamics code that is extensively used in academia and industry to simulate the properties of proteins. In 2009 he co-founded Protabit
with Stephen Mayo out of Caltech to develop computational protein design tools. This led naturally to incorporation of AI and machine learning approaches for protein engineering studies.
|Jeff Orr||AI World||Emerging Technologies and the Future of AI|
Conference Content Director
Jeff Orr is the Conference Content Director for AI World 2018. With nearly 30 years of experience at consumer startups, Fortune 100 enterprise, and industry analyst firms, he brings a pragmatic approach to complex topics. Most
recently, Jeff was a research director at ABI Research focused on emerging technologies including AI, user interfaces, wearables, and mobile computing. Previously, he was responsible for wireless technology projects in corporate
strategy for The Walt Disney Company.
His analysis and opinions on emerging technology have been widely published, in global publications including The Wall Street Journal, The NY Times, Financial Times, TheStreet.com, and
Enterprise Mobility Exchange.
|Pawel Osterreicher||deepsense.ai||Seminar: Enterprise Machine Learning & Deep Learning|
Director of Strategy & Business Development
Pawel is responsible for creating and executing the company’s strategy and driving sales. Prior to joining deepsense.ai Pawel spent over 6 years as Management Consultant and Manager in The Boston Consulting Group, where
he worked on a broad range of strategic, operational and analytical projects. Before BCG Pawel worked as an Associate in M&A Boutique and an Analyst at a mining company in Australia.
|Leslie Owens||MIT Sloan School of Management ||Cognitive Computing|
Executive Director MIT CSR
|Scott Parker||Sinequa||Strategic Business Functions and AI|
Director of Product Marketing
Scott has a deep
history in the enterprise software business helping organizations to succeed by becoming Information-Driven. He has served in a variety of key roles including Software Development Lead, Professional Services Director, Business
Solutions Consultant and Product Expert. Scott began his professional career as a Software Engineer and Systems Analyst with Bloomberg BNA. While at BNA, Scott earned a graduate degree in Software Engineering from Carnegie Mellon
University and then went on to become a Senior Director at Vivisimo where he spearheaded the implementation of the company’s go-to-market strategy.
Scott was a founding member of the IBM Watson Group where his team engaged
clients to explore the art of the possible around amplifying human expertise and alleviating the cognitive burden of knowledge workers in all areas of the enterprise. Scott joined Sinequa at the beginning of 2017 where he and his
team work relentlessly to make sure stakeholders across the globe understand the real and potential benefits of becoming Information-Driven.
|Aalpen Patel, MD||System Radiology at Geisinger Health System, Pennsylvania ||AI in Healthcare|
Dr. Patel is a physician engineer,
informatician, active teacher and researcher, he has a special interest in machine and deep learning, mathematical modeling of biological processes, informatics and 3D printing. He is the Chair of Department of Radiology and the
Medical Director for 3D Imaging and Printing laboratory for Geisinger and leads informatics efforts in Radiology. Dr. Patel has published 90 research articles, review articles, textbook chapters and abstracts and has given several
lectures at regional, national and international radiology meetings.
Dr. Patel is an electrical engineer and clinically he is an Interventional Radiologist and his clinical research interests include dialysis access management
and interventional oncology. He trained at Temple University Hospital and M. D. Anderson Cancer Center. Dr. Patel began his career in 2001 as Assistant Professor of Radiology at the University of Pennsylvania School of Medicine
and an Interventional Radiologist at Hospital of the University of Pennsylvania.
He led Radiology and Interventional Radiology simulation program at Penn Medicine Clinical Simulation Center. He has been in various leadership
positions at Geisinger for past 7 years. He is boarded in Diagnostic Radiology, Interventional Radiology and Clinical Informatics and a Fellow of the Society of Interventional Radiology.
|Nick Patience||451 Research||Plenary Session|
Co-Founder & CRO
|Brian Pearce||Wells Fargo||Implementing Enterprise AI|
Senior Vice President, Enterprise AI
Over his 25-year
career in financial services, Brian has led a variety of business development, product management, project management, business analysis and product operations functions. During Brian’s 16 years with Wells Fargo, he and his
teams have led large, multi-channel efforts including Mobile Remote Deposit, Apple Pay, P2P payments, Transfers, Bill Pay and the launch of an online brokerage platform. Brian was the head of the mobile banking function for Wells
Fargo from 2011-2014, a period of explosive growth and innovation. Prior to Wells Fargo, he worked for both industry leaders such as First Data Corporation and Anderson Consulting, as well as a startup.
|Antigone Peyton||Intellectual Property and Technology Law Group||Enterprise AI Strategies Theater|
Legal Innovation Advisor + Counsel
leads the Intellectual Property and Technology Law practice at Protorae Law in the Washington, DC area. Antigone's focus on IP and tech law issues includes a particular interest in social media, IoT, cybersecurity, blockchain,
data analytics, and AI. A prolific speaker and technophile, Antigone regularly writes and speaks about the practical impact of privacy regulations, data security issues, cloud computing, cryptocurrency and blockchain tech, social
media platform activities, and other technology law complexities. Before she joined Protorae Law, Antigone founded an intellectual property and tech law boutique firm and managed the e-discovery group at Finnegan in Washington,
DC. Before law school, Antigone conducted scientific research involving biophysics and magnetic resonance studies at a large university medical center. All of these experiences sharpened her focus on the business impact of the
law and the practical aspects of technology innovation. You can find her musing on Twitter's platform (@AntigonePeyton) and blogging at DecodingIP.com.
|Karl Pfeiffer||Function (AI)||Workshop: Deploying and Scaling Enterprise AI Systems|
|Tom Plasterer, PhD||AstraZeneca ||AI in Pharma|
US Cross-Science Director, R&D Information
Dr. Plasterer has pursued interests in bioinformatics, clinical informatics systems biology and biomarker discovery over the last twenty years in both industry and academia. He co-founded PanGenX (a Personalized Medicine/Pharmacogenetics
Knowledge Base start-up), directed the project planning and data interpretation group at BG Medicine, and was an adjunct professor in the department of Chemistry and Chemical Biology at Northeastern University. He now leads FAIR
data initiatives and is responsible for the data, analytics and information strategy within Research & Development Information at AstraZeneca. In these roles at AstraZeneca, Dr. Plasterer has established and executed the data,
information and analytics strategy which includes knowledge representation, vocabulary & metadata services, semantic visualization, text analytics and business case development. This strategy has been deployed to build the
competitive intelligence framework for R&D, a shared annotation capability and a linked analytics capability.
|Tulia Plumettaz, PhD||Wayfair||Going from Big Data to AI|
Associate Director, Data Science Operations
Tulia Plumettaz, Associate Director of Data Science, leads algorithm development and deployment for Wayfair’s merchandising business unit which spans more than 10 million products, 10,000 suppliers and 25 million images.
Prior to Wayfair, Tulia led the operations research team at Bridj--a--VC backed public transportation services company prior to its acquisition by the Australian transit authority. She also worked as an oil & gas field engineer
designing power transmission lines connecting the factory to the power grid in Colombia. Her Ph.D. work focused on theoretical market design for human kidney exchanges. Tulia has a Ph.D. in Operations Research from Columbia University,
and a bachelor and masters in Electrical Engineering from Universidad De Los Andes in Bogota, Colombia.
|Mia Puzo||Nuance Communications, Inc.||AI Technology Solutions Theater|
Security SME Manager, Security Product Management
Mia Puzo first gained interest in biometrics while working as a UX designer in the Professional Services team. After learning more about it, she joined the Security team as a Manager and Fraud Prevention SME. She is experienced
in guiding customers through security and fraud related aspects of biometrics deployments.
|Shriram Ramanathan, PhD||Lux Research||Going from Big Data to AI|
As a Senior Analyst
at Lux Research, Shriram leads the Industrial Big Data & Analytics team. He brings nearly 20 years of experience spanning technology development, business strategy and operations. Shriram has led cross-functional teams on multi-million
dollar projects and has helped senior management develop a comprehensive understanding of new business opportunities in several emerging technology areas such as artificial intelligence, robotics, wearables, Internet of Things
(IOT), healthcare, clean energy and advanced materials. He has negotiated alliances, identified and conducted due diligence on acquisition targets, and developed strategies for growing into new geographical markets. In addition,
he has helped accelerate innovation within companies by establishing frameworks for lean innovation, design thinking, and business model design.
Prior to joining Lux, Shriram founded his own company to develop and commercialize
IOT/wearable products to address needs in the healthcare sector. In addition to developing business growth strategy for his company, he also established detailed blueprints for sensor deployment and data analytics. Before that,
he held positions at Cornell University, United Technologies and Evonik Corporation.
Shriram obtained his Ph.D. from the University of Minnesota.
|Sam Ransbotham, PhD||MIT Sloan Management Review||Emerging Technologies and the Future of AI|
Sam Ransbotham ia an associate
professor and the William S. McKiernan '78 Family Faculty Fellow at Boston College’s Carroll School of Management as well as the MIT Sloan Management Review guest editor for its Artificial Intelligence and Business Strategy
Dr. Ransbotham’s research interests include IT security, social media and the strategic use of IT. In 2014, he was awarded an NSF CAREER Award for his analytics-based research in security. His recent research appeared
in Marketing Science, Management Science, MIS Quarterly, Information Systems Research and the INFORMS Journal on Computing
. Dr. Ransbotham was also awarded one of eleven inaugural Google and WPP Marketing Awards to support
research into how online media influences consumer behavior, attitudes, and decision-making.
|Hadley Reynolds||Cognitive Computing Consortium||Cognitive Computing|
Co-Founder & Managing Director
|Michael Ringel, PhD||Boston Consulting Group (BCG)||AI in Pharma|
Senior Partner and Managing Director
Ringel is a Senior Partner and Managing Director in BCG’s Boston office, and BCG's Global Topic Leader on Research & Product Development. Michael has worked for a range of biotech and pharmaceutical clients, with a focus
on R&D Strategy, Operations and Organization.
Prior to joining the firm, Michael worked in academia, pursuing research in theoretical population dynamics and conducting field experiments in the Amazon basin near Manaus,
Brazil. He has a B.A. summa cum laude in biology from Princeton University where he graduated #1 in the department, a Ph.D. in biology from Imperial College (NSF and Fulbright Fellowships awarded) and a J.D. cum laude from Harvard
Law School. He sits on the Board of The Nature Conservancy in Massachusetts.
|Larry Ross||InterContinental Hotels Group (IHG)||Workshop: Deploying and Scaling Enterprise AI Systems|
Senior Operations Manager Global Service Support
|Tom Ryder||MassRobotics||SEMINAR - State of the Technology: Making Robots Intelligent, Cognitive and Aware|
Thomas Ryden is the
Executive Director of MassRobotics. MassRobotics is a non-profit organization whose mission is to help grow the next generation of robotics companies. Prior to joining MassRobotics Mr. Ryden was the founder and CEO/COO of VGo Communications,
Inc. While at VGo Mr. Ryden oversaw the development and launch of the VGo telepresence robot.. Previously, Mr. Ryden was Director of Sales & Marketing at iRobot Corporation. Under his leadership iRobot secured over $300M in
contracts and revenue from its government and industrial products increased from $2M to over $80M annually. In addition Mr. Ryden held roles in program management, overseeing the development of some of iRobot’s most successful
products. Mr. Ryden serves as the co-chairman of the robotics cluster of the Massachusetts Technology Leadership Council and is on the Robotics Technology Advisory Panel for ASME. Mr. Ryden has a B.S. in Electrical Engineering
from the University of Vermont and an MBA from Bentley University.
|Manish Sainani||Splunk||AI Technology Solutions Theater|
Director - Product Management
First ML Hire @ Splunk. Joined Splunk in Oct 2014 as a Product Manager responsible for incorporating Machine Learning and Advanced Analytics into the Core Platform and solutions. Prior to Splunk, lead Product Management for Azure
Machine Learning (Azure ML), a fully-deployed ML SaaS on the Microsoft Azure Cloud and was responsible for taking the service live in Summer 2014 Diehard Seahawks fan!!!
|Parna Sarkar-Basu||Brand and Buzz Marketing||SEMINAR - State of the Technology: Making Robots Intelligent, Cognitive and Aware|
Parna Sarkar-Basu, an innovation marketing strategist, was instrumental in creating the robot technology category and ecosystem along with the founders of iRobot. She appears frequently as a speaker at key industry events and
leads executive discussions on topics ranging from innovation and entrepreneurship to tech trends and automation. Events she has participated in includes Variedy Tech Day (user conference), AI World-WITI, ISPIM Innovation Forum,
Boston GreenFest, MassTLC, HUBweek, MIT CIO Symposium (lunch roundtables), Sales and Marketing Innovators and WITI Summit. Leveraging her two passions – technology and brand building – Parna humanizes corporate brands,
builds thought leaders, simplifies the complex and creates industry buzz to elevate companies to new heights. She has been instrumental in propelling tech companies into innovation leaders in highly competitive markets, including
artificial intelligence, internet of things (IoT), enterprise software, storage systems and robots.
|Curt Savoie||Massachusetts Department of Revenue||Implementing Enterprise AI|
Chief Analytics Officer
|Drew Scarano||WorkFusion||AI Technology Solutions Theater|
Vice President, Head, North American Sales
Drew Scarano is Head of North American Sales at WorkFusion. Drew has held various senior roles in sales for 18 years. His experience is in building & developing a world class sales force that continually out exceed quota
goals. Drew received a BA in Economics & Marketing from Ottawa University.
|Anthony Scriffignano, PhD||Dun & Bradstreet||Plenary Session|
Senior Vice President & Chief Data Scientist
Anthony Scriffignano in an internationally recognized data scientist with experience spanning over 35 years, in multiple industries and enterprise domains. Dr. Scriffignano has extensive background in linguistics and advanced
algorithms, leveraging that background as primary inventor on multiple patents worldwide. He provides thought leadership globally. Recently, he briefed the US National Security Telecommunications Advisory Committee regarding reports
to the President on Big Data Analytics and Emerging Technologies Strategic Vision. Additionally, Scriffignano provided expert advice on private sector data officers to a group of state Chief Data Officers and the White House Office
of Science and Technology Policy. He also served as a forum panelist and keynote speaker at the World Internet Conference hosted by Chinese President Xi Jinping in Wuzhen, China. He was recently published in CIO Review, Huffington
Post, Mint (India) and quoted in various publications including China Daily, Xinhua and Peoples Daily. He was profiled by InformationWeek and by BizCloud, and is a recurring CXOTalk guest. He regularly presents at business, government
and academic venues globally regarding emerging trends in data and information stewardship, the “Big Data” explosion, artificial intelligence, multilingual challenges in business identity and malfeasance in commercial
|Ganesan Shankar, PhD||Babson College||Cognitive Computing|
Associate Professor Technology, Operations, and Information Management
G. Shankaranarayanan (Shankar) obtained his Ph.D. in Management Information Systems from The University of Arizona, Eller School of Management. His research interests cover three primary areas: (1) Modeling and managing data
and metadata in information systems, (2) Managing data quality for decision support, and (3) economic perspectives in data management. His research has appeared in journals including Journal of Data Management, Decision Support
Systems, Communications of the ACM, Communications of the AIS, Journal of Information Technology Management, Journal of Computer Information Systems, International Journal of Information Quality, ACM Journal on Data and Information
Quality and IEEE Transactions on Knowledge and Data Engineering. His research has won the best paper awards at the International Conference on Information Quality (ICIQ) and at the Workshop of Information Technology and Systems
(WITS). He serves as the Area Editor of the International Journal of Information Quality and as an Associate Editor of the ACM Journal for Data and Information Quality. Shankar has taught several courses ranging from introductory
courses in information systems to advanced courses in data management and systems design. He received the Computer World Laureate honor from the Computer World Honors Program in 2008. He currently is a faculty in Information Technology
Management in Babson College.
|Yichen Shen, PhD||Lightelligence||Emerging Technologies and the Future of AI|
Yichen Shen is a co-founder and CEO of Lightelligence. He received his Ph.D. degree in Physics from MIT in 2016, where his research focused on nanophotonics and artificial intelligence. Through his Ph.D., Yichen has published
more than 25 peer-reviewed journal papers and has filed 10 US patents, including first authored papers in Science, Nature Photonics, and ICML (the top machine learning conference). In 2017, Yichen received Forbes 30 under 30 Global
and MIT Technology Review 35 Innovators under 35 (TR35) China.
|Erica S. Shenoy, MD, PhD,||Harvard Medical School||AI in Healthcare|
Associate Chief, Infection Control Unit, Massachusetts General Hospital; Assistant Professor of Medicine
Dr. Shenoy is an infectious disease physician at Massachusetts General Hospital, where she serves as Associate Chief of the Infection Control Unit. She is an Assistant Professor of Medicine at Harvard Medical School. Her research
has evaluated the clinical, operational and economic impact of competing infection control strategies for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) through clinical research
and mathematical modeling and leveraging electronic health records for infection control surveillance.
She collaborates with experts in machine learning on developing real-time risk prediction models for Clostridium difficile
infection. She leads multidisciplinary efforts at MGH to reduce hospital acquired infections including Catheter-Associated Urinary Tract Infections (CAUTIs), surgical site infections, and to reduce the transmission of resistant
organisms. As part of this work, and as the Healthcare Epidemiology Lead for MGH’s Clinical Data Animation Center, Dr. Shenoy has developed approaches for automated detection of ventilator associated events. Dr. Shenoy additionally
serves as Medical Director of the MGH Ebola and Other Special Pathogens Treatment Center.
|Ted Slater||Cray||AI in Pharma|
Global Head, Scientific AI & Analytics
Ted Slater is Global
Head of Scientific AI & Analytics at Cray, Inc. He has also held senior roles in several large pharmaceutical companies, content providers, and biotechnology startups, including Pfizer, Merck, and Thomson Reuters. He is an
expert in the application of artificial intelligence and semantics-based methods to pharmaceutical R&D and similar areas. He holds an M.A. in Molecular Biology from the University of California at Riverside, and an M.S. in
Computer Science from New Mexico State University. He is based in Northwestern Lower Michigan.
|Calvin Smith||Wipro||AI & Real-time IoT|
Director & Head of IoT Partner Engineering
As Director & Global Head of IoT Partner Engineering at Wipro, Calvin and his team combine Wipro IP & services with Partner products & offerings to create differentiated E2E Solutions designed to maximize Customer
ROI. Prior to this role, Calvin led IoT Strategy & Organic Innovation at Dell EMC.
|Richard Soley, PhD||Object Management Group (OMG)||AI and Real-Time IoT|
Chairman and CEO
Dr. Richard Mark Soley is Chairman and CEO of the Object Management Group®, also leading the Cloud Standards Customer Council™ the Industrial Internet Consortium®. Previously cofounder and former Chairman/CEO of
A. I. Architects, he worked for technology companies and venture firms like TI, Gold Hill, Honeywell & IBM. Dr. Soley has SB, SM and PhD degrees in Computer Science and Engineering from MIT.
|Shankar Srinivasan||Adobe||Plenary Session|
Head of Engineering, Adobe Cloud Platform, AI and ML
|Chad Steelberg||Veritone||Plenary Session|
A visionary serial entrepreneur who has co-founded several highly successful internet software companies, Chad serves as the Chairman and CEO of Veritone. Chad has brought innovation and thought leadership to Artificial Intelligence,
transforming businesses worldwide and solving human problems on a vast scale. With his brother, Ryan Steelberg, he has created tremendous shareholder and industry value by establishing AdForce, the world’s largest publicly
traded, centralized, independent ad-serving solution, which received the Smithsonian Award for the Best Technology in 2000 before being sold to CMGI; 2CAN Media, the third-largest internet advertising sales organization, also sold
to CMGI; and dMarc Broadcasting, the largest centralized radio advertising network company, sold to Google in 2006.
|Andrew Stein||Splunk||AI Technology Solutions Theater|
Principal Product Manager, Machine Learning and Advanced Analytics
is a principal product manager at Splunk for machine learning and artificial intelligence. He’s spent the last 18 years as a programmer, architect, and data scientist building, delivering, and supporting mathematical modeled
outcomes across multiple verticals including finance and IOT. He spends 80 % of his time preparing data for machine learning and 20% complaining about the need to prepare data for machine learning.
|Benji Sucher||TD Bank (Layer 6 AI)||AI Technology Solutions Theater|
COO and VP
Benji is VP and COO (Layer 6 AI), TD Bank Group following the acquisition of Layer 6 by TD in January 2018. Prior to joining Layer 6, Benji was a VP of M&A and Integration at Constellation Software (TSX:CSU). At Constellation,
he was responsible for acquiring, integrating and growing software companies around the world. Benji also worked in Private Equity and holds a CPA designation, which he obtained from PwC.
|Manoj Suvarna||Hewlett Packard Enterprise||AI Technology Solutions Theater|
HPC & AI Category Manager
Manoj Suvarna is a product leader for the High Performance
Computing (HPC) & Artificial Intelligence (AI) portfolio within Hybrid IT in N. America. In this role, his responsibilities span across product P&L, competitive positioning, marketing, sales & channels enablement and
|Krish Swamy||Wells Fargo||Implementing Enterprise AI|
Senior Vice President, Enterprise Analytics and Data Science
Krish Swamy is Senior Vice President in Enterprise Analytics and Data Science, part of Wells Fargo’s Data Management & Insights organization. In this role, Krish is the Data Science lead for Machine Learning and Artificial
Intelligence. He has nearly 20 years of financial services and management consulting experience, spanning a wide range of analytic functions.
Krish is responsible for advancing cutting-edge data science and data engineering
practices and is frequently engaged in applying new algorithms to long-standing banking and customer challenges that have defied solutions. He is also a key influencer in the overall Big Data direction at the bank, and he is redefining
the practice and application of Business Intelligence through a consulting team. Krish has a passion for solving deep customer needs, driving an exceptional customer and employee experience, and connecting with the latest in technology
to do so.
|David Sweenor||TIBCO Software, Inc.||Going from Big Data to AI|
Global Analytics & Industry Marketing Leader
Sweenor has close to 20 years of hands-on business analytics experience spanning product marketing, business strategy, product development, IoT, BI & advanced analytics, data warehousing, and manufacturing. In his current role
as the Global Analytics Marketing Leader at TIBCO, David is responsible for GTM strategy for the advanced analytics portfolio. Prior to joining TIBCO, David has served in a variety of roles – including a Business Analytics
Center of Competency solutions consultant, competitive intelligence, semiconductor yield characterization, data warehousing and advanced analytics for IBM, SAS, Quest, and Dell. David holds a B.S. in Applied Physics from Rensselaer
Polytechnic Institute in Troy, NY and a MBA from the University of Vermont.
|Said Tabet||DellEMC||AI and Real-Time IoT|
Lead Technologist for IoT Strategy and OMG Board Member
|Lolita Taub||Backstage Capital||Cognitive Computing|
Lolita Taub is the Principal for Backstage Capital’s Headliner
Fund I, and a millennial woman with a 9-year long career in B2B Enterprise Tech. Her interests lie in the intersection of AI and business. She’s followed AI for several years; interviewed investors, founders, and experts
in the field; written an Enterprise AI series on Huffington Post; and given a TEDx talk on raising AI. Lolita has also been featured in Forbes' article: Why We Need More Women Taking Part In The AI Revolution.
background provides a unique perspective on how AI will impact people, the tech industry, and business innovation as a whole.
|Michael Thormann, PhD||Origenis GmbH||AI Technology Solutions Theater|
Michael Thormann is co-founder of Origenis and leads its AI driven drug discovery technology platform MOREsystem® with a therapeutic focus on CNS drugs. He is the originator of the patent research platform Cippix(R), and
a range of protein- and ligand-based drug design methods, QSPR, parallel evolutionary search algorithms, and multiparametric optimization techniques. He received his Ph.D. in biochemistry from the University of Leipzig in 1998
and held post-doctoral positions in Cheminformatics in Barcelona.
|Priyanka Tiwari||Interactions||AI Bot Workshop|
Senior Product Marketing Manager
Bio coming soon.
|Nguyen Anh Tuan||Boston Global Forum (BGF)||Enterprise AI Strategies Theater|
Nguyen Anh Tuan is the Director of The Michael Dukakis Institute for Leadership and Innovation (MDI), the Co-founder and Chief Executive Officer of The Boston Global Forum (BGF). Tuan is also the Founder and Chairman of the VietNamNet
Media Group and the Founder and Editor-in-Chief of VietNamNet, Vietnam’s preeminent online newspaper. Additionally, Tuan was the Founder and CEO of VASC Software and Media Company and VietNet, the first Internet service provider
in Vietnam. For his contributions to his native land, the Government of Vietnam named Tuan one of the nation’s 10 most outstanding young talents in 1996.
|Gary Tyreman||Univa||Enterprise AI Strategies Theater|
Gary Tyreman brings more than 20 years of executive leadership to his role as the President and CEO of Univa Corporation. As CEO, he leads all of Univa's global operations and is the architect of Univa's data center automation
strategy, which combines the deep expertise of Grid Engine with Univa's solutions for optimizing and managing IT workloads including containers.
|Denise Valentine||Aite Group||Enterprise AI Strategies Theater|
Denise Valentine is a senior analyst at Aite Group in wealth management, focusing on investment management topics such as portfolio technology and related processes ranging from traditional portfolio systems to portfolio management
techniques leveraged within digital advice platforms. Ms. Valentine further focuses on data analytics, artificial intelligence, and retirement industry trends, such as the Department of Labor fiduciary rule and the defined contribution
segment. Ms. Valentine spent several years with Aite Group evaluating the institutional asset management market. She has supported clients in the selection of technology systems, the identification of product gaps, market entry
initiatives, and vendor-firm acquisitions. Ms. Valentine is widely quoted in the press in publications including Financial Times, The Wall Street Journal, Reuters, BusinessWeek, NPR's Marketplace, and Pensions & Investments,
among others. She has spoken at and attends industry events in the United States and Europe. Prior to joining Aite Group, Ms. Valentine worked in the global sourcing group at BlackRock, identifying high-risk vendors in business
services segments. She was responsible for conducting vendor due diligence to identify and mitigate risk issues, defining contract requirements, and coordinating the firm’s ongoing vendor management program in her business
segments. She has served as a senior analyst with research advisory firm Celent, looking at wealth and institutional topics, and as a business risk manager with GE Capital Services, where her responsibilities included acquisition
integration activities, implementation of corporate risk policies, risk assessments, and project management in the United States and Europe. She is trained in Six Sigma black belt principles. Ms. Valentine also has 10 years in
the areas of marketing, research, performance measurement, and portfolio administration for multimarket, multiproduct asset managers. In this capacity she held series 3, 7, 63 and 65 FINRA licenses.
|John R. Walker||Novartis||AI in Pharma|
Head of Core Data and Analytics, NIBR Informatics
John Walker is Head of
Core Data and Analytics at the Novartis Institutes for BioMedical Research (NIBR) where he is responsible for leading a global team focused on integrating NIBR’s vast data resources and providing a data platform for data
scientists to do their work. Previously at NIBR he was responsible for leading a team who provides IT systems to support pre-clinical safety, DMPK and early phase clinical development. Prior to joining NIBR in 2010, John worked
at Infinity Pharmaceuticals for 8 years where he lead the development of Infinity's clinical IT systems and was responsible for data management. In addition to 10+ years of drug discovery and development experience, John also worked
at Bowstreet, an enterprise software company, that was acquired by IBM. John holds a B.A in Biochemistry from Bowdoin College.
|Yiqing Wang, PhD||Microsoft||SEMINAR - Enterprise Machine Learning & Deep Learning|
|James Wester||IDC||Executive Summit|
Research Director, Global Payments
James Wester is Research Director for IDC Financial Insights responsible for the global payments practice. Mr. Wester’s core research coverage includes the evolution of payment networks and technology, developing fraud
and security risks, and legal and regulatory issues. Based on his background covering the mobile payment space, Mr. Wester’s research also includes a particular emphasis on mobile and alternative payment methods and the threats
and opportunities now facing the entire payment ecosystem from evolving mobile technologies.
|David Weinberger, PhD||Harvard||Cognitive Computing|
Berkman Klein Center for Internet & Society
|Eliot Weinman||AI World||Plenary Session|
Founder and Conference Chair
Mr. Weinman is Founder and Conference Chair of AI World. For the past two decades Eliot has been a successful entrepreneur and veteran high tech market expert. AI World was his fifth publishing start-up which he sold recently
to Cambridge Innovation Institute. AI World and companion online magazine AI Trends have become the nation’s largest independent AI business event and integrated media platform covering the enterprise AI market. He previously
founded and sold four leading publishing firms whose media products had become the largest in their respective industry. He has been a publisher, editor and author of numerous magazines, newsletters, books and research studies
in diverse areas of advanced technology. His writings have appeared in publications such as the New York Times, Forbes, San Francisco Chronicle and The Washington Post.
Eliot received is M.S. in Computer Engineering from
Boston University and completed a research fellowship in A.I. with GE and MIT where he worked on developing expert systems for the quality inspection of jet engine turbine blades. Before starting his first media business, he headed
up the AI group at a top 10 property insurance company (Hanover Insurance) where he implemented one of the nation’s earliest commercial expert systems in underwriting and claims. He also headed advanced engineering groups
at the MIT Draper Labs.
Eliot has created more than 200 events in emerging technology markets, including Mobile Commerce World, 4G World, Mobile Internet World, RoboNexus, RoboBusiness, Client/Server Computing and Application
Development Conference & Expo. Mr. Weinman has partnered with, consulted to and sold his businesses to many of the industry’s leading computer hardware, software, publishing and research firms. He has taught courses at
Northeastern University in AI and knowledge engineering. Previously he earned his B.S. in Accounting at SUNY Albany, and was a CPA for several large CPA firms.
|Scot Whigham||Function (AI)||Workshop: Deploying and Scaling Enterprise AI Systems|
Scot Whigham is CEO of
Function-AI and a visionary leader, with over 20+ years of AI, Technology, and Operations Experience. He is a graduate of Georgia Institute of Technology. He is a recognized business leader, focused on developing AI strategies
and implementing AI for large enterprises.
He has worked in IT Operations since 1998 managing IT Service Desk Support, Network/Telecommunications, database administration, software development, and data center operations. His current focus is on technology organizational
strategy, digital workforce technology, and operational excellence through data analytics.
His main focus is to understand and solve big problems for his customers.
Prior to Function AI, Scot was Director of Global IT
Service Support at InterContinental Hotel Group.
Mr. Whigham and his team at the Intercontinental Hotel Group won the Technology Association of Georgia’s 2017 Most Creative Solution and Product Launch of the Year awards
for their cognitive technology platform strategy and deployment.
|Kesha Williams||Chick-fil-A Corporate||AI Startup Pavilion and Theater Presentations|
Senior Software Engineer
Kesha Williams is an award-winning software engineer with over 20 years’ experience specializing in full-stack web development. She has trained and mentored thousands of software developers in the US, Europe, and Asia while
teaching at the university level. She routinely leads innovation teams in proving out emerging technologies and shares her learnings at conferences across the globe. In her spare time, she leads the Georgia chapter of Technovation,
mentors women in tech, and conducts free "Hour of Code" workshops for children at her local library.
|Kazuo Yano, PhD||Hitachi Ltd||Plenary Session|
Yano is a Fellow, Corporate Officer, Hitachi Ltd. He has pioneered the measurement and analysis of social big data. The wearable sensor for this purpose has been introduced as a historical wearable device by Harvard Business Review.
He has succeeded quantifying the happiness by sensors and recent work on the multi-purpose AI has been applied to over 60 cases. He has applied over 350 patents and his papers are cited by over 2500 papers. His book, "The New Invisible
Hand," is cited as one of top-10 business books in Japan in 2014. He is a Fellow of the IEEE. He received many international awards.
|Les Yeamans||RTInsights||AI and Real-Time IoT|
Founder & Executive Editor
|Mike Zalis, MD||Harvard Medical School||AI in Healthcare|
Associate Professor of Radiology
has accrued experience as a developer, an academic physician, and an entrepreneur. Having studied computing and biophysics on East and West coasts of the US, he has pursued research and clinical practice at MGH since 2000, where
he has focused on software methods to extend imaging interpretation and interventional procedures. Starting in 2012, he led the QPID development team at Partners healthcare, and eventually spun-off and co-founded QPID Health in
2013, a venture-backed, Boston based medical informatics company, which was was subsequently acquired in 2016.
|Litao Zhang, PhD||BMS||AI in Pharma|
Vice President, Leads Discovery & Optimization, Disease Sciences & Biologics
Litao Zhang is the Vice President of Leads Discovery and Optimization, a centralized function in Discovery that is a data generating engine for Bristol-Myers Squibb R&D. Her organization delivers comprehensive data packages
from concept to first-in- human for over 200 projects annually across multimodalities and across all therapeutic areas.
Litao championed the Leveraging Technology Initiatives which delivered first-rate technology infrastructure
across Research sites. Her team is one of the critical contributors for four commercially launched drugs: SPRYCEL®, FARXIGA®, DAKLINZA®, and ELIQUIS®. Litao has established new functional capabilities for biologics
screening and translational research in addition to her responsibilities for driving BMS 2020 site transformation, enhancing Discovery capabilities in India and leading academic alliances in China. During the past 5 years, her
team established 10 proprietary technology platforms for immune-oncology (IO), which played essential roles in supporting over 20 IO biologic drug candidate nominations.
Recently, she launched the BMS Network of Women as one
of the co-founders with the vision to enhance female business impact through creation of a powerfully diverse and globally inclusive workplace. In 2017, she became a member of the Scientific Advisor Board (SAB) of the Innovation
Center for Immune Therapy at Tsinghua University, Beijing, China.
|Shanrong Zhao, PhD||Pfizer||Seminar: AI in Personalized Medicine and Digital Health|
Director, Computational Biology
More than twenty
years of experience in computational biology with strong interdisciplinary skills in computer science, biostatistics, computational biology and machine learning. Shanrong recieved his Ph.D from The Chinese Academy of Sciences,
and a second M.S in computer science from San Diego State University. He is a recognized pioneer in next generation sequencing, big data analysis, cloud computing and machine learning. In the past five years, he published more
than 20 papers in the field of RNA sequencing and was invited to speak at more than 30 national and international meetings. Shanrong has led multiple cross-functional teams to successfully implement pipelines and informatics systems,
including QuickRNASeq, QuickIsoSeq, QuickMIRSeq, Rainbow, Stormbow.
|Alex Zhavoronkov||Insilico Medicine||AI in Pharma|
Dr. Zhavoronkov is the founder
and CEO of Insilico Medicine, a Baltimore-based leader in the next-generation AI for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics,
the Biogerontology Research Foundation and co-founded YLabs.AI. Since 2012 he published over 100 peer-reviewed research papers and two books. He organizes the annual Aging Forum and Artificial Intelligence for Healthcare Forum
at EMBO/Basel Life in Basel. Dr. Zhavoronkov is an adjunct professor at the Buck Institute for Research on Aging.